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PREFACE 
INTRODUCTION 
Assisted Reproduction Technologies (ART) have been developed to treat infertility since 
1790, when the first case of artificial insemination was performed.  Since then, multiple and 
dramatic advances have been made in the field of infertility research through the employment of 
a variety of species; enabling people, whom without the use of these techniques, would not be 
capable of reproducing.  While the development of techniques to overcome infertility has been at 
the forefront of reproductive research, investigation into the causes of infertility have also been, 
and continue to be, equally as important as the remedies.  It is well established that one major 
contributor to female infertility is maternal age.  According to the Society for Assisted 
Reproductive Technology (SART) statistics for 2007, oocyte retrievals in women <35yrs had a 
43.1% live birth rate, while women 41-42yrs of age had a 14.3% live birth rate.  Furthermore, the 
average number of embryos per transfer was 2.2 in the <35yr age group and increased to 3.1 in 
the 41-42yr age group, indicating that there is a decline in either oocyte or embryo quality with 
age as well.  While maternal age is known and can be a fairly reliable indicator of fertility; 
oocyte and embryo quality contribute significantly to fertility as well, but are much more 
difficult to determine.  Oocyte quality is generally assessed by appearance and meiotic stage of 
the oocyte at the time of collection and insemination.  There are few guidelines that aid in 
discriminating a competent from a non-competent oocyte and the process is subjective and 
heavily dependent upon the embryologists’ skill and expertise.  Embryo quality is more defined 
in that there is an expected, timely progression of cell division and development through 
preimplantation.  It is reasonably simple to identify poor or bad embryos based upon morphology 
and embryonic arrest during the cleavage stages; however, it remains difficult to identify a high 
quality embryo based upon anything besides development rate and morphological quality score.  
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Because of poor predictive value of embryo morphology, virtually all human ART clinics 
practice multiple embryo transfers, which while increasing pregnancy and live birth rates, also 
result in multiple births which can lead to pre and perinatal complications.  Techniques such as 
preimplantation genetic diagnosis (PGD) have been developed in attempts to remedy this 
problem, however the results have been unreliable and the procedure is detrimental to the 
embryo.  Due to the fact that there are currently no reliable, objective ways to determine oocyte, 
and even embryo, quality, it is imperative to ascertain methods to measure oocyte quality that 
will improve selection of oocytes and embryos in ART clinics and increase pregnancy success 
rates.  These methods are only possible with a more complete understanding of the cellular and 
molecular properties of oocytes and preimplantation embryos.  A key component of all cells, 
including oocytes and embryos, is the mitochondrion, which produces energy and maintains its 
own DNA for encoding proteins necessary for energy production.  Defects in either the proteins 
responsible for energy production, the mitochondrial DNA (mtDNA) genome, or other 
contributing factors can lead to loss of oocyte competence (failed fertilization) and embryo 
quality (embryonic arrest, incompetent placentas, pregnancy loss).  Unquestioningly, human 
oocytes and the embryos derived from them would be the optimal material to use for performing 
studies on oocyte quality and embryo development.  However, practical and ethical constraints 
prevent the use of human material for intensive, potentially terminal studies; thus, compelling 
researchers to find and use suitable animal models instead.  It is important that studies are 
conducted with animals closely related to humans due to the wide diversity in cellular, molecular 
and endocrine mechanisms used by different mammals in their reproductive strategies.  The non-
human primate (NHP) is the most befitting animal model for human reproduction due to 
evolutionary closeness and the dramatic similarities in reproductive function and preimplantation 
development.  Furthermore, because studies in human preimplantation development are 
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restricted to the use of discarded oocytes from infertility clinics, the use of the NHP has 
established the rhesus macaque as an excellent research model for human reproduction due to the 
availability of normal, viable oocytes and embryos from fertile animals.  Therefore, the overall 
goals of this study were to evaluate mitochondria in NHP oocytes and embryos and to determine 
how mtDNA mutations and mitochondrial function affect oocyte and embryo quality.  
Specific Aim 1.1: To determine if the rhesus macaque can be utilized as a clinically 
translational model for mitochondrial mutations identified in human IVF.  
Specific Aim 1.2: To determine if the rate of mitochondrial mutations in rhesus macaque 
oocytes and IVF produced embryos is increased due to gonadotrophin stimulation.  A high 
proportion of presumably normal oocytes give rise to developmentally incompetent embryos in 
human IVF programs.  Pre-implantation embryos generated by IVF show high frequencies of 
abnormal development and early demise.  A direct relationship between mitochondrial mutations 
in oocytes and embryos and reproductive success has not been demonstrated; however, it is 
generally assumed that there must be a sufficient number of functional mitochondrial genomes in 
the embryo in order for it to develop and implant successfully.  A mitochondrial mutation that 
has been described in human oocytes and embryos is termed the “common deletion" or 
?mtDNA4977.  The reason for this mutation is currently unknown, however, an important 
question is whether or not this deletion is caused by gonadotrophin stimulation.  In order to 
determine this, employment of the rhesus macaque as a clinically translational model is vital. 
Specific Aim 2: Due to the frequency of the rhesus mtDNA common mutation in 
gonadotrophin stimulated, rhesus macaque MII oocytes and IVP embryos, we hypothesize 
that the common mutation will also be present in embryonic stem (ES) cells derived from 
IVP produced embryos.  We propose that the presence of numerous mtDNA deletions and 
point mutations may actually reflect the quality of affected oocytes or primate ES cells lines.  
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Primate ES cell lines may harbor mutant mtDNA that may further accumulate during cell 
culture, and thus have consequences for long-term viability. 
Specific Aim 3.1: To determine if the presence of mutations in the mtDNA control region, 
as well as the mitochondrial polymerase, PolG, are associated with aging in the rhesus 
macaque. 
Specific Aim 3.2: To determine if in the presence of mutations in the mtDNA control region 
are associated with meiotic failure in oocytes.  In order to understand the significance of 
mutations within the mtDNA genome, it is imperative to examine the region of the genome that 
controls OXPHOS, replication and transcription.  In addition to investigating the occurrence of 
mutations in the mtDNA control region, we can determine if aging is a cause of mtDNA damage 
as well identifying mutations that may be associated with failure of oocytes to mature to 
metaphase II, enabling them to be fertilized. 
Specific Aim 4: To determine if gonadotrophin stimulation efficiency and oocyte and 
embryo quality can be improved through optimization of gonadotrophin stimulation 
protocols. 
Our laboratory has been working with the Caribbean Primate Research Center (CPRC) 
for approximately 4 years in an effort to establish a reputable rhesus macaque IVF program using 
the CPRC as a resource to provide high quality rhesus macaque oocytes, embryos and sperm.  In 
order to obtain rhesus macaque reproductive material of the highest quality, we tested three 
modifications to the previously established gonadotrophin stimulation protocols. 
Specific Aim 5.1: To determine if expression levels of genes controlling mitochondrial 
dynamics are correlated to the failure of oocytes to resume meiosis.  
Specific Aim 5.2: To determine if expression levels of genes controlling mitochondrial 
dynamics are correlated to important preimplantation development time points. 
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Interest in the mitochondrion and its role in the preimplantation mammalian embryo has 
had a recent resurgence and it is understood that mitochondria undergo a variety of species-
specific reorganizations during early preimplantation development. It is possible that the 
localization of mitochondria in rhesus zygotes is a result of mitochondria undergoing fusion and 
fission processes during preimplantation resulting in the microtubule network guiding the 
mitochondria to their pronuclear location.  Our lab has recently found that monkey oocytes have 
an abundance of gene involved in the control of mitochondrial fusion, fission, movement and 
replication.  Therefore we speculate that mitochondrial trafficking is important for fusion and 
fission mechanisms and may impact oocyte and embryo quality. 
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CHAPTER 1 
BACKGROUND AND SIGNIFICANCE 
Oogenesis and Preimplantation Development 
Oogenesis begins early in fetal development with the formation of primordial germ cells 
(PGCs) which populate the fetal ovary.  PGCs migrate along the hind gut during gestation to the 
region adjacent to the mesonephros that becomes the genital ridge.  PGCs are the sole source of 
adult germ cells and once established in the developing ovary are referred to as oogonia.  
Oogonia undergo several rounds of mitotic division over a period of several months until shortly 
before birth, when meiosis is initiated.  The primary oocytes progress through prophase I of the 
first meiotic division before arresting at the diplotene stage.  Diplotene oocytes are characterized 
by diffused chromosomes surrounded by an intact nuclear membrane known as the germinal 
vesicle (GV).  With the resumption of meiosis, which occurs shortly after puberty, the interphase 
chromatin condenses, the germinal vesicle membrane breaks down (GVBD), the spindles form 
and chromosomes segregate.  Extrusion of the first polar body marks the completion of the first 
meiotic division.  Oocytes then arrest again at metaphase II (MII).  Completion of the second 
meiotic division only occurs after fertilization and the extrusion of the second polar body.  The 
interaction of maternal and paternal pronuclei at syngamy is characterized by tight association of 
both male and female pronuclear envelopes with close alignment of the nucleoli.   In humans and 
non-human primates, pronuclear membrane breakdown and commencement of the first mitotic 
division ensues without actual fusion of the pronuclear envelopes, as is seen in a multitude of 
other species (reviewed by (Levron et al., 1995). 
Mitochondria and Reproduction 
Mitochondria are considered entirely maternally inherited.  Although sperm carries 
paternal mitochondria into the oocyte at fertilization, they are normally eliminated in early 
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embryonic development by ubiquitin-tagging of the sperm surface.  During the first half of fetal 
development, mitochondria number around 10 in each premigratory PGC and increase to 
approximately 200 in each original oogonium.  Mitochondria then increase exponentially until 
the diplotene stage of meiosis where they arrest.  At birth, there are approximately two million 
oocytes and each immature primordial oocyte contains about 6000 mitochondria (Jansen and 
Burton, 2004; Shoubridge and Wai, 2007).  Once puberty is reached, primordial follicles contain 
oocytes arrested at the GV stage of development.  Upon fertilization, during mitosis, mtDNA 
synthesis and mitochondrial replication are inhibited as cleavage divides the mitochondria from 
the fertilized oocyte among the daughter cells of the developing embryo.  This process 
progressively reduces the mtDNA copy number per cell, or blastomere in the embryo, from the 
0.5–5 million found in the oocyte at ovulation to approximately 10 per cell by the time 
gastrulation begins.  This process establishes a genetic bottleneck of mtDNA.  The mitochondrial 
bottleneck theory states that a limited number of mtDNAs (1-200) are the only mtDNAs selected 
to undergo replication.  These genetic founder mtDNAs replicate to give rise to almost all the 
100,000 mtDNAs in mature MII oocytes (Jenuth et al., 1996).  Typically, prior to mtDNA 
replication, if oocytes contain a small percentage of mtDNAs with rearrangements, then random 
selection of a limited number of founder mtDNAs would likely select normal mtDNAs for 
replication.  At this point, the literature varies significantly about both the number of 
mitochondria in each GV oocyte and the number of mtDNA copies per mitochondria.  Upon 
resumption of meiosis and during maturation, cytoplasmic growth of oocytes recruited for 
ovulation indicates that mitochondrial numbers have increased, and in some species, i.e. NHP 
and porcine (Gibson et al., 2005; Spikings et al., 2007) mtDNA replication occurs, increasing the 
mtDNA copy number from GV to MII.  This replication event does not appear to occur in the 
mouse. 
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Mitochondrial Function 
Mitochondria are traditionally known as the powerhouses of the cell; the primary source 
of ATP production.  While this is true, the mitochondrion is an infinitely more complicated and 
interesting organelle.  The mitochondrion, which evolved from an oxidative ?-proteo-bacterium, 
approximately 2 billion years, ago joined forces with a glycolytic motile cell evolving into what 
we know currently as a eukaryotic cell.  Over approximately 1.2 billion years a symbiotic 
relationship evolved in which the mitochondrion became specialized in energy production and 
the nucleus-cytosol became the driving force behind structure.  As this relationship evolved 
further, essentially all genetic function from the mitochondrion (~1500 genes) became part of the 
chromosomal nuclear DNA.  However, the mitochondrial genome did not disappear completely 
and continues to retain the core subunits of the enzyme complexes of mitochondrial oxidative 
phosphorylation (OXPHOS) (Wallace, 2008).  Thirteen polypeptide-encoding genes, 2 rRNA 
genes and 22 tRNA genes, all essential to OXPHOS, remain encoded by the mitochondrial 
genome, rendering the mitochondrial DNA (mtDNA) genome essential to energy production and 
cell function.  Mitochondria generate energy through the electron transport complexes (ETC) by 
oxidizing hydrogen with oxygen to generate heat and ATP.  Two electrons are passed 
sequentially, either from NADH+H+ to complex I (NADH dehydrogenase) or from succinate to 
complex II (succinate dehydrogenase), to ubiquinone (coenzyme Q) to give ubisemiquinone 
(CoQH) and then ubiquinol (CoQH2).  Ubiquinol transfers its electrons to complex III 
(cytochrome c oxidoreductase), which transfers them to cytochrome c.  From cytochrome c, the 
electrons ow to complex IV (cytochrome c oxidase, COX) and then to 1/2 O2 to give H2O.  The 
energy released from the ETC is used to pump protons out of the mitochondrial inner membrane 
through complexes I, III, and IV, creating an electrochemical gradient.  The potential energy 
stored in the inner membrane is coupled to ATP synthesis by complex V (ATP synthase).  As 
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protons ow back into the matrix through a proton channel in complex V, ADP and Pi are 
bound, condensed, and released as ATP.  Matrix ATP is then exchanged for cytosolic ADP by 
the adenine nucleotide translocator (ANT).  As a by-product of OXPHOS, mitochondria generate 
reactive oxygen species (ROS), in the forms of O2- (superoxide anion radical), H2O2 (hydrogen 
peroxide) and OH (hydroxyl radical).  Superoxide anion can be converted to hydrogen peroxide 
which can then be converted to highly reactive hydroxyl radicals, rendering mitochondria key 
targets for oxidative damage (reviewed by (Wallace, 2005).  H2O2, in conjunction with 
superoxide anion, can damage cells by allowing the most reactive metabolite, OH, to form via 
superoxide dismutase (SOD) and the Haber-Weiss reaction (Halliwell, 1989). 
Because gametes and embryos require energy, which is produced by the conversion of 
ADP to ATP via glycolysis and OXPHOS; a process by which O2 is intrinsic through its role as 
an electron acceptor, O2-, H2O2 and OH have been well established as factors of oxidative stress 
in in vitro culture systems.  The production of excessive amounts of intracellular ROS during in 
vitro embryo culture is thought to disrupt metabolic activity and is therefore detrimental to 
embryo development (Guerin et al., 2001).  The concentration of oxygen at which embryos are 
cultured has shown to be a key factor in regulating OXPHOS and ROS production in several 
species including bovine (Nagao et al., 1994), mouse (Goto et al., 1993) and human (Catt and 
Henman, 2000; Dumoulin et al., 1999).  Furthermore, reduced O2 concentration that more 
closely resembles physiological O2 results in higher blastocyst rates in mice (Dumoulin et al., 
1999), sheep (Bernardi et al., 1996) and bovine (Lonergan et al., 1999).  In mammals, ovulation, 
fertilization, and early embryo development occur in the oviduct.  Embryos then migrate to the 
uterus, where implantation occurs.  Oviductal O2 concentration is dramatically lower than 
atmospheric concentration (Mastroianni and Jones, 1965) with the uterus maintaining an even 
lower O2 concentration than that of the oviduct (Fischer and Bavister, 1993).  Thus there is a 
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decreasing O2 concentration gradient that embryos encounter as they progress through the 
reproductive tract.  Traditionally, in vitro culture systems employed 5% CO2 in atmospheric air 
(approximately 20% O2).  Studies in the last two decades have shown that culture of embryos 
under an O2 concentration more closely resembling that of the oviduct (5% O2) result in 
increased embryonic viability (Dumoulin et al., 1999), decreased H2O2 production and DNA 
fragmentation (Kitagawa et al., 2004) and significantly increased pregnancy and birth rates as 
well as blastocyst rate and quality (Waldenstrom et al., 2009). 
In addition to energy production, mitochondria are key regulators of apoptosis.  
Apoptosis can be initiated through the activation of the mitochondrial permeability transition 
pore (mtPTP) in response to energy deficiency, increased oxidative stress, excessive calcium, 
and other factors.  A complete understanding of the mtPTP remains to be elucidated, however it 
is thought to be composed of the inner membrane ANT, the outer membrane voltage-dependent 
anion channel (VDAC), Bax, Bcl2, and cyclophilin D.  When the mtPTP opens, membrane 
potential decreases and ions equilibrate between the matrix and cytosol, causing a phenomenon 
called mitochondrial outer membrane permeabilization (MOMP) and subsequent swelling of the 
mitochondria.  This results in the release of the contents of the mitochondrial inner membrane 
space (cell death promoting factors such as cytochrome c) into the cytosol.  Upon release, 
cytochrome c activates factors which downstream activate caspases that propagate and execute 
apoptosis. 
The mitochondrial theory of aging (or the oxidative stress theory) holds that oxidative 
damage to the mtDNA genome can lead to DNA strand breaks, deletions and mutations and 
subsequent dysfunction of the respiratory chain.  The most current version of this theory by 
(Sohal and Weindruch, 1996) states that  
“a chronic state of oxidative stress exists in cells of aerobic organisms even under 
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normal physiological conditions because of an imbalance of pro-oxidants and 
antioxidants.  This imbalance results in a steady-state accumulation of oxidative 
damage in a variety of macromolecules. Oxidative damage increases during 
aging, which results in a progressive loss in the functional efficiency of various 
cellular processes.”  
Mitochondrial DNA is much more susceptible to ROS damage than nuclear DNA due to 
its proximity to the site of ROS production, as well as the lack of histones and the limited repair 
function of mtDNA.  It is well established that as the proportion of mutated mtDNA increases, 
the energetic output of the mitochondria subsequently declines, ROS production increases, and 
the propensity for apoptosis increases, leading to loss of tissue function (Wallace, 2005).    
Despite decades of research in support of the mitochondrial theory of aging, the exact 
connection between aging and mitochondria continues to be a hot topic of debate and study.  One 
question of interest is whether mtDNA mutations are a cause or consequence of aging.  The 
mitochondrial theory of aging supports the idea that mtDNA mutations are a result of the aging 
process (Sohal and Weindruch, 1996).  The alternative theory is the concept of clonal expansion 
of mtDNA mutations that accumulate over the lifetime of an individual, leading to dysfunction 
of the respiratory complex, followed by the observed aging phenotypes and age-related diseases 
(Elson et al., 2001).  This is of particular interest in post-mitotic cells and tissues, such as skeletal 
muscle, myocardium, brain and oocytes.  As previously stated, the mitochondrial bottleneck 
theory states that limited number of mtDNAs are selected for replication.  If the oocyte selected 
for ovulation contains a small percentage of founder mtDNA with rearrangements that escaped 
the bottleneck, then the resulting oocyte would contain an abnormally high percentage of 
rearranged mtDNAs and thus a high percentage on non-functional mitochondria.  It is well 
established that mtDNA mutations must meet a critical threshold in order to result in age-related 
phenotypes.  However, it is currently unknown exactly how long this process takes, i.e., do 
mtDNA mutations occur early in life and through years of replication clonally expand as the 
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individual ages?  Thus, it would follow that the mtDNA mutations are a cause of aging, instead 
of a result.  Most likely, some combination of both of these processes is the culprit of aging and 
age related diseases.  
Genome and Replication 
Mammalian mtDNA is a double-stranded, closed-circular molecule of approximately 
16.6 kb in the human and non-human primate (Figure P1).    
 
Figure P1. Human mtDNA Genome 
The two strands of mtDNA are classified as either the heavy (H) or light (L) strand.  The 
H strand is thusly named because it is guanine rich and it encodes most of the regulatory 
information: 2 rRNAs, 14 tRNAs and mRNAs for 12 of 13 polypeptides encoded by mtDNA.  
The L strand only encodes 8 tRNAs and 1 mRNA.  There are only two non-coding regions of 
mtDNA.  The primary region is a triple stranded structure called the displacement loop (D-
Loop), approximately 1kb long, within which is the site of heavy strand replication (OH).  The D-
Loop is triple stranded due to the frequent termination of the nascent H strand approximately 
700bp downstream of OH, which remains annealed to the parental L strand, thus leaving three 
strands present in the D-Loop.  Also located within the D-Loop are the sites of the promoters for 
both H and L strand transcription, as well as multiple binding sites for mitochondrial 
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transcription factor A (Tfam).  The second non-coding region is approximately two thirds of the 
mtDNA length from the OH, is only ~30bp in length, and is the origin of replication for the light 
strand (OL).    
Mitochondria are unique organelles in that they require the contribution of both the 
nuclear and mitochondrial genome.  The bulk of mitochondrial proteins are encoded in the 
nucleus, synthesized in the cytoplasm, then imported and processed inside the mitochondrion.  
The mitochondrial genome contributes a small subset of proteins necessary for the OXPHOS 
pathway and is quite different from the nuclear genome for several reasons: 1) Cells contain 
hundreds of mitochondria and each mitochondrion contains 2-10 identical copies of mtDNA, 
while each cell only contains one copy of the nuclear genome, 2) The mitochondrial genome is 
considered maternally inherited, with the paternal contribution being eliminated by an ubiquitin-
dependent mechanism during fertilization (Sutovsky et al., 1999, 2000).  However, this process 
of ubiquination has been questioned in the human as a paternal mitochondrial contribution has 
been detected in children in specific cases, thus leading to mitochondrial heteroplasmy (St John 
and Schatten, 2004).  However, for the scope of this report, we will consider mtDNA to be only 
maternally inherited. 3) The mtDNA genome has considerably less efficient repair mechanisms 
than that of nuclear DNA.  There is only one known mtDNA polymerase, gamma or PolG; and 
the only repair function is the 3’-5’ exonuclease linked to the catalytic subunit of PolG.  In all 
vertebrates, PolG is encoded in the nucleus and contains two subunits: a large catalytic subunit 
that harbors the 3’-5’ exonuclease and 5’deoxyribose phosphate (dRP) lyase activities, and a 
smaller accessory subunit which increases both the catalytic activity and processivity of the 
catalytic subunit.  PolG has conserved polymerase and exonuclease domains and the 
combination of the two domains is responsible for the high-fidelity of mtDNA replication with 
an average error rate in humans of approximately 1 error/500,000 bp in vitro (Lee and Johnson, 
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2006; Longley et al., 2005).  Diseases such as progressive external ophthalmoplegia (PEO), 
Kearns Sayer syndrome (KSS), Alpers syndrome and ataxia, as well as symptoms of premature 
menopause, progressive muscle weakness, parkinsonism, and male infertility are coupled with 
mutations in human PolG (Luoma et al., 2004; Mancuso et al., 2004; Naviaux and Nguyen, 
2004; Van Goethem et al., 2001; Zeviani et al., 1988; Zeviani et al., 1989).  Reported mutations 
are primarily recessive and generally associated with other PolG mutations or with mutations in 
other genes that encode proteins involved in mtDNA replication, i.e. Twinkle.   
Twinkle (PEO1) is an mtDNA helicase important for mtDNA replication and to date 
appears to be the rate limiting step in mtDNA replication initiation (Korhonen et al., 2003; 
Spelbrink et al., 2001; Tyynismaa et al., 2005).  Mutations in Twinkle are associated with 
multiple mtDNA deletions and inhibition of Twinkle expression in cultured cells results in rapid 
mtDNA depletion, suggesting that it is required for mtDNA maintenance.  In contrast, 
overexpression of Twinkle in transgenic mice results in increased mtDNA copy number 
(Tyynismaa et al., 2004).  Furthermore, Twinkle helicase activity is stimulated by the 
mitochondrial single stranded DNA-binding protein (SSBP1), which acts as a stabilizer of 
mitochondrial chromosome and nucleoid structure (Korhonen et al., 2003).  Together with PolG, 
these proteins form a minimal replisome (Figure P1) capable of synthesizing 16kb lengths of 
DNA in cell–free systems (Kaguni, 2004; Korhonen et al., 2003), since PolG alone is unable to 
support DNA synthesis.  Twinkle also co-localizes with Tfam and SSBP1.   
Mitochondrial Transcription 
Transcription of mtDNA takes place following interaction between the nuclear-encoded 
regulatory proteins and regions within the mitochondrial D-Loop.  Transcription requires 
mitochondrial RNA polymerase (Polmt) (Tiranti et al., 1997), Tfam (Fisher and Clayton, 1985, 
1988), and at least one of the transcription factors Tfb1m or Tfb2m (Falkenberg et al., 2002).  
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Several studies suggest that transcription is initiated bi-directionally at two promoters, HSP and 
LSP for heavy and light strands, respectively, within the D-Loop regulatory region (Clayton, 
2000; Shadel and Clayton, 1997).  Light strand transcription commences from the LSP to the 
second conserved sequence block within the D-Loop region, generating a complementary RNA 
sequence (Xu and Clayton, 1995).  Binding of PolG to the resulting sequence enables replication 
of the heavy strand to initiate within the D-Loop.  Both promoters share a critical upstream 
enhancer that serves as the recognition site for Tfam, an HMG-box protein that stimulates 
transcription through specific binding to upstream enhancers. Tfam can bend and unwind DNA 
and is linked to its ability to stimulate transcription upon binding DNA (Fisher et al., 1992).  
Both Tfb1m and Tfb2m proteins work together with Tfam and Polmt to direct initiation from 
HSP and LSP.  Knockdown of the Tfb2m isoform results in reduced mtDNA transcription and 
copy number, while knockdown of Tfb1m appears to have no effect on mtDNA transcription or 
replication (Matsushima et al., 2005).  Termination of mitochondrial transcription is associated 
with the specific initiation site for H-strand transcription, via the mitochondrial transcription 
termination factor (mTERF) (Martinez-Azorin, 2005). 
Mitochondrial Dynamics 
 In mammalian cells, the size and shape of mitochondria varies widely, ranging from long, 
interconnected tubules to individual, small spheres. In some cell types, the mitochondrial 
population consists mostly of tubules, which constantly migrate back and forth along 
microtubule tracks (Chen and Chan, 2004).  In other cell types, the actin cytoskeleton is used for 
transport (Hollenbeck and Saxton, 2005).  During migration along these tracks, individual 
mitochondria can encounter each other and undergo fusion, resulting in mixing of both lipid 
membranes and intra-mitochondrial content (Detmer and Chan, 2007).  Conversely, individual 
mitochondria can divide by fission to yield two or more smaller mitochondria.  In addition to 
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changes occurring during migration, the internal structure of mitochondria can change in 
response to their physiological state.  The length, shape, size and number of mitochondria are 
maintained by fusion and fission.  At steady state, dynamic events are balanced to maintain the 
overall morphology of the mitochondria. When this balance is disturbed, remarkable transitions 
in mitochondrial shape can occur.  
 Genetic studies have shown that cells with a high fusion:fission ratio have few, long and 
highly interconnected mitochondria (Bleazard et al., 1999; Chen et al., 2003; Sesaki and Jensen, 
1999; Smirnova et al., 2001).  Conversely, cells with a high fission:fusion ratio have higher 
numbers of smaller, spherical mitochondria referred to as fragmented mitochondria (Detmer and 
Chan, 2007).  These fragmented mitochondria lead to apoptosis by regulating the release of 
cytochrome C and caspase into the inner membrane space (Detmer and Chan, 2007; Youle and 
Karbowski, 2005).  Mitochondria proliferate on their own during the cell cycle in a manner 
similar to bacterial division.  The dynamics of mitochondrial division are essential for 
mitochondrial function.  A fundamental role of mitochondrial division in multiple cell types is 
the maintenance of appropriate distribution of mitochondria.  Mitochondrial division can lead to 
a distorted mitochondrial network that allows areas of the cell to be devoid of mitochondria, 
resulting in altered cellular division.  It has been shown in mammals that disruption of 
mitochondrial division can result in loss of membrane potential, increased ROS and oxidized 
proteins, as well as mtDNA loss (Lackner and Nunnari, 2008).  The ability to identify areas of 
high and low mitochondrial density within cells may lead to the ability to identify normal 
mitochondrial distribution patterns.  
It has been shown in pronuclear oocytes and early cleavage stage embryos in multiple 
species, including hamster (Barnett et al., 1996) and mouse (Van Blerkom, 1991), that 
mitochondria have a distinct perinuclear translocation and that perturbations from these patterns 
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result in embryonic lethality.  In the human, mitochondrial localization patterns are significantly 
different between individual oocytes and between and among cohorts.  However, pronuclear 
oocytes that showed a pronounced asymmetrical mitochondrial distribution during syngamy 
continued to show an asymmetrical distribution after the first cell division, and between 
blastomeres throughout embryo development.  When analyzed individually, the blastomeres 
containing less mitochondria also had lower ATP content compared to blastomeres with higher 
mitochondrial content (Van Blerkom et al., 2000).  It is well established that during the early 
stages of development, embryo competence depends upon ATP produced by mitochondria 
inherited from the mother (Gardner and Lane, 1998).  During the early stages of embryo 
development, energy is produced by OXPHOS via amino acids, lactate and pyruvate, with the 
glucose pathway proving to be harmful at this stage; indicating that a threshold of mitochondrial 
activity is necessary to support energetic demands (Tarazona et al., 2006).  Once embryonic 
genome activation begins, the metabolic activity of the embryo increases as it becomes capable 
of using alternative pathways such as anaerobic glycolysis, allowing mitochondrial activity to 
decrease.  It has been shown that embryos that are developmentally incompetent have lower 
mitochondrial activity and inhibited cleavage.  While the lack of mitochondrial organization has 
been correlated to poor implantation in the human (Scott and Smith, 1998), the exact influence of 
mitochondrial distribution on embryo competence remains to be determined.   
The molecular analysis of mitochondrial dynamics began in 1997 with the identification 
of the Drosophila mitofusin gene Fzo (Hales and Fuller, 1997).  Fzo is a mitochondrial outer 
membrane GTPase required for mitochondrial fusion during spermatogenesis.  The core genes 
mediating mammalian mitochondrial fusion are Mfn1, Mfn2 and Opa1.  Mfn1 and Mfn2, the 
mammalian homologues to Fzo, are large GTPases with similar homology and topologies that 
reside on the outer mitochondrial membrane (Chen and Chan, 2004).  Opa1 is an inter membrane 
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space protein and is also essential for fusion (Detmer and Chan, 2007).  The exact relationship 
between these proteins remains unclear; however cells lacking any of the three proteins have 
been shown to have inhibited respiratory capacity.  Additionally, the contact between the inner 
and outer membranes, where these proteins reside, is essential to mitochondrial fusion (Detmer 
and Chan, 2007).  During apoptosis structural changes in mitochondria, such as fragmentation, 
occur, leading to increased fission activity.  Concurrently, mitochondrial outer membrane 
permeabilization (MOMP) causes the release of contents of the intermembrane space, including 
cytochrome c, which is sequestered in the cristae, into the cytoplasm.  Once in the cytosol, 
cytochrome c activates caspases that propagate and execute apoptosis.  Inhibition of fission 
blocks mitochondrial fragmentation, reduces cytochrome c release and can reduce or delay 
apoptosis (Detmer and Chan, 2007).  The core genes mediating mitochondrial fission are Drp1, 
Fis1 and MTP18.  Drp1 is a large dynamin-related GTPase located primarily in the cell cytosol.  
A portion of Drp1 moves to the mitochondrial tubule where it interacts with Fis1 (Parone et al., 
2006).  Fis1 is a transmembrane protein anchored to the mitochondrial outer membrane.  Both 
Drp1 and Fis1 have been implicated in mitochondrial outer membrane permeability and mediate 
downstream apoptosis (Chen and Chan, 2004).  Inhibition of Drp1 has been shown to delay 
mitochondrial division and partially inhibit apoptosis.  MTP18 is a mitochondrial protein that 
contributes to the balance of mitochondrial fission and fusion.  Changes in the expression levels 
of MTP18 interfere with the balance of mitochondrial fission and fusion; whereas loss results in 
increased mitochondrial fusion and an increase results in increased number of fragmented 
mitochondria (Tondera et al., 2005). 
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Figure P2: Proposed interaction of genes involved in the control of mitochondrial dynamics, 
movement and mtDNA replication. 
Mitochondria, which are among the most abundant and mobile membrane-bound 
organelles, move along both microtubules and actin, using microtubule-based molecular motors 
for long distance movements (Morris and Hollenbeck, 1995) (Figure P2).  Distribution of 
mitochondria varies in response to multiple regulatory cues such as energy requirements, growth 
factors and mitochondrial membrane potential (Chada and Hollenbeck, 2004; Miller and Sheetz, 
2004; Morris and Hollenbeck, 1993).  Conventional kinesin moves mitochondria to the plus ends 
of microtubules, while dynein moves them toward the minus ends (Pilling et al., 2006; Tanaka et 
al., 1998).  Two research groups identified two different components important for transport; 
Milton (Stowers et al., 2002), involved with kinesin heavy chains, and Miro (Guo et al., 2005), a 
GTPase which is an integral outer mitochondrial membrane protein.  Mutation in either of these 
genes appears to abolish anterograde mitochondrial transport.  Glater et al. (Glater et al., 2006) 
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showed that kinesin, Milton, and Miro work together in anterograde transport and that Milton 
attaches kinesin to mitochondria through Miro.  Pink1, a putative serine–threonine kinase that 
localizes to the outer mitochondrial membrane, has been shown to have a role in cellular 
protection against oxidative stress and to affect mitochondrial dynamics.  Recent ndings have 
shown that Pink1 interacts with the Miro/Milton complex and that overexpression of either Miro 
or Milton can suppress mitochondrial fragmentation induced after Pink1 silencing (Weihofen et 
al., 2009).  Pink1 and Parkin, a gene associated with Parkinson’s disease, are linked in a common 
pathway that is involved in the protection of mitochondrial integrity and function (Pridgeon et 
al., 2007).  Our lab has recently found that monkey oocytes have an abundance of Miro1 and 2, 
Milton, Pink1, Parkin, Mfn1, Mfn2 and Drp1 (unpublished data).  Therefore we speculate that 
mitochondrial trafficking is important for fusion and fission mechanisms and may impact oocyte 
and embryo quality. 
Oocyte and Embryo Quality 
In order to adequately assess oocyte and embryonic potential, both qualitative and 
quantitative biology of the structure must be considered.  The morphological appearance or 
qualitative assessment of oocytes and embryos coupled with growth rates are heavily relied upon 
in ART programs.  Basically, the oocyte or embryo that best fits the established standards of 
what it “should” look like is considered the most likely to develop normally.  While it is 
generally accepted what a “bad” embryo or oocyte looks like, it is entirely subjective as to what a 
“good” embryo looks like and is not a definitive indication of embryonic viability.  While there 
are likely many avenues to explore when developing better methods for evaluating oocyte and 
embryo quality, two approaches we are particularly interested in are the proper timing of the 
resumption of meiosis and mitochondrial distribution and dynamics.   
In order for proper fertilization to occur, the GV-stage oocyte, which is arrested at the 
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diplotene stage of metaphase I, must first resume meiosis and arrest again a MII, with the 
extrusion of the first polar body.  The use of standard ART protocols in human infertility 
treatment can result in the failure of meiotic resumption in 15 – 27% of oocytes within the 
standard 36 h after the administration of human chorionic gonadotrophin (hCG) (de Vos et al., 
1999; Junca et al., 1995).  Immature oocytes (GV or MI) may be collected at oocyte retrieval 
along with mature MII oocytes.  Typically, oocytes are collected 32-34 hours post hCG and 
cultured for approximately 4 hours, after which some immature oocytes will extrude a polar 
body and may subsequently be used for IVF.  Multiple studies reveal that immature human MI 
and GV oocytes maturing overnight or even within a few hours have lower fertilization rates in 
comparison to oocytes that were mature at retrieval (Balakier et al., 2004; de Vos et al., 1999; 
DeScisciolo et al., 2000; Huang et al., 1999; Nogueira et al., 2000; Shu et al., 2007; Strassburger 
et al., 2004).  Embryos originating from immature GV and MI oocytes incubated overnight to 
attain maturity were qualitatively inferior when compared to those resulting from oocytes that 
were mature at the time of retrieval (DeScisciolo et al., 2000; Nogueira et al., 2000).  It is fairly 
common for immature MI oocytes from human IVF cycles to be fertilized and develop into 
‘morphologically normal’ embryos (de Vos et al., 1999; Huang et al., 1999; Junca et al., 1995; 
Strassburger et al., 2004), however these embryos generally lead to reduced pregnancy and live 
birth rates (de Vos et al., 1999; Vanhoutte et al., 2005). 
Mitochondria as Indicators of Oocyte and Embryo Quality 
When considering the quantitative aspects of mitochondria in oocyte and embryo 
development, it is well established that both oocytes and embryos require a certain threshold of 
OXPHOS capacity to function and develop normally.  During mitosis, mitochondria are 
distributed randomly among the blastomeres in the embryo.  If a particular blastomere does not 
acquire a sufficient number of ATP producing mitochondria, it may fragment, thus affecting the 
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qualitative assessment of the embryo (Cummins, 2004). 
Because mitochondria play such a significant role in oocyte and embryonic development, 
oocytes and embryos are also subject to the same oxidative damage as any slow or non-dividing 
cell or tissue.  The accumulation of mtDNA mutations due to ROS damage or the aging process 
affects oocytes and embryos in the same manner that they affect skeletal muscle or neuronal 
tissue.  The time at which these mutations accumulate and how they are passed from one 
generation to the next are areas of extensive research.  Slow and non-dividing cells such as 
neurons, skeletal muscle and oocytes appear to harbor a higher percentage of mitochondrial 
mutations than rapidly dividing cells, possibly due to the proximity of mtDNA to highly 
mutagenic ROS generated in the mitochondria (Brenner et al., 1998).  Understanding why a high 
proportion of seemingly normal oocytes give rise to developmentally incompetent embryos 
following IVF is increasingly important in infertility research.  Oocytes arrested at the GV stage 
are relatively anaerobic and subsist in a metabolically quiet environment, which may protect the 
genome from DNA damage and mutation.  Their OXPHOS needs are likely quite minimal, as 
long as there is sufficient available glucose, anaerobic ATP production may satisfy all energy 
needs.  The presence of mtDNA deletions and point mutations in oocytes may have no effect 
prior to a replication event.  However, once ATP requirements increase, metabolic deficiencies 
or replication disorders in some infertile women and in women of increased reproductive age 
may cause qualitatively normal oocytes to develop abnormally.  In other words, mitochondrial 
dysfunctions or genetic anomalies present in the oocyte may be critical determinants of 
developmental competence of the embryo (Barritt et al., 2000b; May-Panloup et al., 2005; Van 
Blerkom, 2004).  Human IVF pre-implantation embryos show high frequencies of abnormal 
development and early demise, with further losses seen after intra-uterine transfer, when 
measured by outcome per embryo.   
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While a direct relationship between mitochondrial mutations in oocytes and embryos and 
reproductive success has not been demonstrated, it is generally assumed that there must be a 
sufficient number of functional mitochondrial genomes in the embryo in order for it to develop 
and implant successfully (May-Panloup et al., 2005).  A high proportion of genetically abnormal 
mitochondria in the oocyte could potentially reduce the number of functional mitochondria, 
leading to embryonic arrest, failed implantation or mitochondrial disease.  More than 150 
mtDNA rearrangements, including deletions, insertions and duplications have been identified in 
various somatic cells (Wallace, 1993).  These mutations are responsible for a number of 
catastrophic neuromuscular diseases such as Kearns Sayer Syndrome (KSS), chronic PEO, and 
Pearson’s syndrome.  MtDNA rearrangements also accumulate with age and can become more 
prevalent in post-mitotic tissues (Cortopassi and Arnheim, 1990).   
Among the mitochondrial mutations that have been described in humans, one that is 
termed the “common deletion" or ?mtDNA4977 entails the deletion of 4977bp (Barritt et al., 
1999; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995).  This mutation can be detected 
at frequencies as high as 30% to 50% in human oocytes, although its frequency appears to be 
considerably lower in embryos that are generated from the same cohorts of oocytes (Barritt et al., 
1999; Brenner et al., 1998).  Other studies show that oocyte-specific mutations predominate in 
the regulatory control region of the mitochondrial genome (Barritt et al., 2000a; Barritt et al., 
2000b).  Age-dependent accumulations of these mutations in the mitochondrial control region 
may be responsible for impaired transcription and regulated replication of mitochondria in 
oocytes from older women (Barritt et al., 2000b; Michikawa et al., 1999).  Support for age-
dependent increases in mitochondrial mutations comes from studies of skeletal muscle in rhesus 
macaques that not only showed the presence of the ?mtDNA4977 deletion, but also revealed that 
multiple deletions existed in all animals older than 13 years.  In some cases, the deletions were 
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so extensive that large portions of the mtDNA genome were missing (Lopez et al., 2000; 
Mehmet et al., 2001; Schwarze et al., 1995).  These data provide intriguing insights into 
mitochondrial mutations and aging in the human female gamete that warrant further investigation 
in appropriate primate models.   
NHP as a Model to Study Oocyte and Embryo Quality  
NHP models are particularly relevant to study due to their close resemblance to humans 
in anatomy and physiology compared to more commonly employed laboratory animals, such as 
rodents.  The NHP, particularly the rhesus macaque, is the most appropriate animal model to 
study due to evolutionary closeness and the dramatic similarities in reproductive function and 
peri-implantation development.  Rhesus macaque menstrual cycles are similar to those of women 
in length and in steroid and protein hormone profiles.  Similarities in physiology between 
humans and NHP are also evident for spermatogenesis, embryo preimplantation development 
and implantation.  The monkey oocyte is similar in size, shape and appearance to that of the 
human and does not show the pigmented appearance of some livestock species (Michaels et al., 
1982).  Moreover, the developing monkey embryo displays similar requirements to those of 
humans during in vitro embryo culture.  Studies involving ovarian, hormonal, and pituitary 
functions of rhesus macaques have consistently shown biological changes mirroring those known 
to occur in women.  Rhesus monkey ART has been quite successful and provides an excellent 
animal model for human IVF. Furthermore, because of NIH federal restrictions, studies utilizing 
human oocytes and embryos from infertility clinics remain prohibited.  Therefore, the NHP has 
been established as a clinical translational model for understanding mechanisms of oocyte 
maturation, reproductive aging, pre- and peri-implantation development, and derivation of ESCs 
for differentiation and therapeutic and regenerative medicine (Steuerwald et al., 2000).  We 
postulate that mitochondrial dysfunction in oocytes and embryos may occur due to the 
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breakdown of mtDNA repair machinery which alters processes related to mtDNA mutations, 
nucleoid stability and mitochondrial dynamics.  The oocyte is an ideal model to study since it is 
associated with dysfunctions such as a decrease in mitochondrial membrane potential, increase 
of mtDNA damages, chromosomal aneuploidies, the incidence of apoptosis, and changes in gene 
expression.  It has been suggested that these mitochondrial changes may arise from ROS that are 
closely associated with the oxidative energy production and calcium.  Thus understanding 
aspects of mitochondrial dynamics, such as fusion, fission and transport in the oocyte may lead 
to a better understanding of important biological mechanisms and thus leading to new 
therapeutics. 
The central goals of this study were to evaluate mitochondria in NHP oocytes and 
embryos, to determine how mtDNA mutations and mitochondrial function affect oocyte and 
embryo quality and to further establish the rhesus macaque as an excellent comparative model to 
study preimplantation development in the human.  The major topics addressed in this dissertation 
were: 
• determine if there is a large mitochondrial mutation present in rhesus macaque oocytes 
and embryos similar to the common deletion (mtDNA4977) seen in humans 
• determine if mature oocytes and IVF produced embryos from gonadotrophin stimulated 
rhesus macaques harbor a higher proportion of specific mtDNA mutations than immature 
oocytes from non-stimulated monkeys 
• determine if the rhesus common mutation is present in in vitro and in in vivo derived 
embryonic stem cell lines, as well as adult stem cell lines 
• determine if polymorphisms in the mtDNA control region as well as polymorphisms in 
the mtDNA repair mechanism, PolG, are associated with aging 
• determine if failure of oocytes to reach meiotic maturity is due to specific polymorphisms 
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in the mtDNA control region 
• determine if mtDNA control region sequence differences exist between embryos 
• identify methods to improve gonadotrophin stimulation protocols and IVF efficiency at 
the Caribbean Primate Research Center 
• determine if, during syngamy, expression of genes involved in mitochondrial dynamics, 
transport and replication are influenced by meiotic stage of gonadotrophin stimulated 
oocytes at the time of collection 
• determine if expression of genes involved in mitochondrial dynamics, transport and 
replication are influenced by mitochondrial distribution during syngamy 
• determine expression profiles of genes involved in mitochondrial dynamics, transport and 
replication during syngamy and early embryo development 
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CHAPTER 2 
SPECIFIC AIM 1 
Introduction 
Specific Aim 1.1: To determine if the rhesus macaque can be utilized as a clinically 
translational model for mitochondrial mutations identified in human IVF.  
Specific Aim 1.2: To determine if the rate of mitochondrial mutations in rhesus macaque 
oocytes and IVF produced embryos is increased due to gonadotrophin stimulation.  
Understanding why a high proportion of seemingly normal oocytes give rise to 
developmentally incompetent embryos following IVF is a high priority for human infertility 
clinics.  Human IVF preimplantation embryos show high frequencies of abnormal development 
and early demise, with further losses seen after intra-uterine transfer, when measured by outcome 
per embryo.  One hypothesis is that mitochondrial dysfunctions or genetic anomalies in the 
oocyte may be critical determinants of developmental competence of the embryo (Barritt et al., 
2000a; May-Panloup et al., 2005; Van Blerkom, 2004).  More than 150 mtDNA rearrangements, 
including deletions, insertions and duplications have been identified in various somatic cells 
(Wallace, 1993).  These mutations are responsible for a number of catastrophic neuromuscular 
diseases such as Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia 
(CPEO) and Pearson’s syndrome.  Mitochondrial DNA rearrangements also accumulate with 
age, and can become more prevalent in post-mitotic tissues (Cortopassi and Arnheim, 1990).  
Slow and non-dividing cells such as neurons, skeletal muscle and oocytes appear to harbor a 
higher percentage of mitochondrial mutations than rapidly dividing cells, possibly due to the 
proximity of mtDNA to highly mutagenic ROS generated in the mitochondria (Brenner et al., 
1998).  Perhaps these mutations are due to the lack of mitochondrial repair activity by the DNA 
polymerase gamma (PolG) during oogenesis. 
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While a direct relationship between mitochondrial mutations in oocytes and embryos and 
reproductive success has not been demonstrated, it is generally assumed that there must be a 
sufficient number of functional mitochondrial genomes in the embryo in order for it to develop 
and implant successfully (May-Panloup et al., 2005).  A high proportion of genetically abnormal 
mitochondria in the oocyte could potentially reduce the number of functional mitochondria, 
leading to embryonic arrest, failed implantation or mitochondrial disease.  
Among the mitochondrial mutations that have been described in humans, one that is 
termed the “common deletion" or ?mtDNA4977 entails the deletion of 4977bp (Barritt et al., 
1999; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995).  This mutation can be detected 
at frequencies as high as 30% to 50% in human oocytes, although its frequency appears to be 
considerably lower in embryos that are generated from the same cohorts of oocytes (Barritt et al., 
1999; Brenner et al., 1998).  This is intriguing, considering that surplus embryos available for 
analysis in clinical IVF programs are generally classified as developmentally defective.  In 
addition to the ?mtDNA4977 deletion, a further 23 novel mtDNA rearrangements have been 
described in human oocytes and embryos (Barritt et al., 1999).  Using a nested PCR strategy, 
mtDNA rearrangements can be detected in 51% and 32% of human oocytes and embryos, 
respectively.  Multiple rearrangements were detected in 31% of oocytes and 14% of embryos.  
Other studies show that oocyte-specific mutations predominate in the regulatory control region 
of the mitochondrial genome (Barritt et al., 2000a; Barritt et al., 2000b).  Age-dependent 
accumulations of these mutations in the mitochondrial control region may be responsible for 
impaired transcription and regulated replication of mitochondria in oocytes from older women 
(Barritt et al., 2000a; Michikawa et al., 1999).  These data provide intriguing insights into 
mitochondrial mutations and aging in the human female gamete that warrant further investigation 
in appropriate primate models.  Support for an age-dependent increase in mitochondrial 
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mutations comes from studies of skeletal muscle in rhesus macaques that not only showed the 
presence of the ?mtDNA4977 deletion, but also revealed that multiple deletions existed in all 
animals older than 13 years.  In some cases, the deletions were so extensive that large portions of 
the mitochondrial genome were missing (Lopez et al., 2000; Mehmet et al., 2001; Schwarze et 
al., 1995).  The specific aims of this study, therefore, were to determine if mature NHP oocytes 
and embryos generated by IVF have a higher frequency of the rhesus macaque ?mtDNA4977 
deletion (common deletion) than immature NHP oocytes.  
Material and Methods 
Ovarian Stimulation, Oocyte Recovery and In Vitro Fertilization 
All animals were used with approval of the Tulane University’s Institutional Animal Care 
and Use Committee.  Ovarian stimulation and oocyte recovery were performed as previously 
described by Schramm (Schramm et al., 2002).  Briefly, females were observed for signs of 
menstrual activity and were subjected to follicular stimulation via intramuscular injections of 
recombinant human follicle stimulating hormone (FSH) over an eight day period.  On the 9th day 
of FSH injections, the animal was injected with recombinant human chorionic gonadotropin 
(hCG).  Cumulus-oocyte complexes were collected from anesthetized animals by laparoscopic 
follicular aspiration (27-30 hours post hCG) and placed in HEPES buffered TALP (modified 
Tyrodes’ solution with albumin, lactate and pyruvate) medium (Bavister et al., 1983b) at 37°C.  
The cohort of oocytes was randomly split into two groups that were either immediately used for 
mtDNA analysis or subjected to IVF.  Oocytes to be fertilized were transferred to equilibrated 
CMRL medium (Gibco Cell Culture, Invitrogen, Carlsbad, CA, USA) in oil with 5% CO2 at 
37°C.  
Rhesus semen was collected by penile electroejaculation as described by Lanzendorf 
(Lanzendorf et al., 1990).  Following liquefaction for 15 min at room temperature, the sample 
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was washed twice in TALP-HEPES by centrifugation for 7min. at 350g.  Sperm count and 
motility analyses were performed and the spermatozoa were resuspended in TALP-HEPES; then 
the sperm suspension was stored at room temperature.  Approximately 1 hour before 
insemination, spermatozoa were exposed to 1 mM dibutyryl cyclic adenosine 3’,5’-
monophosphate (dbcAMP) and 1mM caffeine for sperm activation (Bavister et al., 1983b).   
For IVF, oocytes were inseminated with 5x104 activated spermatozoa and cultured in 50 
µl drops of CMRL at 37°C in 5% CO2.  Oocytes were examined 10-16 hours post insemination 
for the presence of pronuclei.  Oocytes with pronuclei were cultured for 48 hr (to approximately 
the 8-cell stage) in HECM-9 (Bavister et al., 1983b). 
DNA Purification 
Embryos and oocytes (denuded of cumulus cells using 10mg/ml hyaluronidase dissolved 
in TL-HEPES) were stripped of their zonae pellucidae with acid Tyrode’s solution (Sigma-
Aldrich, St. Louis, MO, USA).  They were individually placed into 0.2 ml PCR tubes with 3 ?l 
of 0.1% polyvinyl alcohol (PVA) in phosphate buffered saline (PBS).  Samples were stored at -
20°C until use.  Prior to PCR, 3 ?l of a mixture of 4x10-4 M sodium dodecyl sulfate (SDS; 
Sigma-Aldrich) and 125 ?g/ml proteinase K (Roche Diagnostics Corp, Indianapolis, IN, USA) 
were added to each tube for cell lysis.  The tubes were incubated at 37°C for 1 hr, and then 
heated to 95°C for 15 min to inactivate proteinase K.   
The gene-specific oligonucleotide primers used in this study were synthesized by Sigma 
Genosys (The Woodlands, TX, USA).  To amplify the internal control mtDNA region and the 
rhesus common deletion simultaneously, the DNA was divided into two 3?l aliquots prior to 
PCR amplification.  Each aliquot was amplified using a MyCycler Thermal Cycler (Bio-Rad, 
Hercules, CA, USA) in a 25 ?l reaction volume containing 1.5 mM MgCl2, 1 IU Taq 
polymerase, 200 ?M each dNTP and 0.5 ?M gene-specific primers using the following 
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amplification profile: 1 cycle of 95°C for 1 min, 30 cycles at 95°C for 25 sec, 62°C for 25 sec 
and 72°C for 2 min, followed by 1 cycle at 72° C for 5 min and then a hold at 4°C.  For the 
nested PCR, 3?l of the first reaction served as a template.  The nested PCR was performed using 
the following profile: 1 cycle of 95°C for 1 min, 40 cycles at 95°C for 25 sec, 62°C for 25 sec 
then 72°C for 2 min followed by 1 cycle at 72° C for 5 min and then a hold at 4°C.  The 
evaluation of PCR results was performed by agarose gel electrophoresis.  Eight microliters of 
nested PCR product and 2 ?l of blue/orange loading dye were separated on 1.5% gel and stained 
with ethidium bromide.  The positive control for the rhesus common deletion was DNA isolated 
from skeletal muscle derived from a 31 yr old male rhesus macaque, amplified under the same 
conditions as the oocytes and embryos. 
 
Figure 1:  Nested PCR strategy used to detect the rhesus common deletion in the mitochondrial 
DNA genome. Primers RhM15.1 (inside arrow) and RhM15.6 (outside arrow) were used as an 
internal control for the presence of mtDNA. RhM15.6 (outside arrow) and RhM7.2 (inside 
arrow) were used in the first PCR amplification. Primers RhM14.8 (outside) and RhM8966 
(inside) were used for the nested PCR reaction to identify the 5703 bp deletion. The dashed 
inside line represents the 5703 rhesus common deletion which is removed in the nested PCR 
reaction if mtDNA mutations are present in the sample. Black bar indicates deleted base pairs. 
PCR Detection of the Rhesus Common Deletion 
To detect the rhesus common deletion, a nested PCR strategy was applied.  
Oligonucleotide sequences were taken from mtDNA sequence analysis by Schwarze (Schwarze 
et al., 1995).  PCR primers were designed based on the corresponding sites in the human mtDNA 
genome.  Primer sequences and corresponding human mtDNA positions are shown in Table 1.  
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Primers RhM15.1 and RhM15.6 were used for amplification of a 599bp internal control mtDNA 
amplicon.  Primers RhM15.1 and RhM7.2 were used in combination with RhM14.8 and 
RhM8966 using a nested PCR strategy to detect the rhesus monkey common deletion as shown 
in Figure 1. 
Table 1.  Polymerase chain reaction (PCR) primer sequences used to detect the rhesus common 
deletion in the mitochondrial genome  
Name mtDNA Location (nt) Sequence (5’-3’)   
RhM15.1   15069    TCCTCCTAGAAACCTGAAACATTGG 
RhM15.6   15643   AAGTATAGGGATGGCTGCTAGAATG 
RhM7.2     7206   GGAATACCCCGACGCTACTCTG  
RhM14.8   14849   AAAATTAGGCAGGCTGCAAGAAGTG 
RhM8966     8966   TCAGTCTACTATTCAACCAGTGGC  
Statistical Analysis 
A 2x2 G test was performed to determine significant differences between percentages of 
non-stimulated oocytes vs. stimulated oocytes; non-stimulated oocytes vs. stimulated, 
unfertilized oocytes; non-stimulated oocytes vs. IVF embryos; and all non-stimulated vs. 
stimulated oocytes and embryos.  The statistical formula used was  
ts = (arcsine ?P1) – (arcsine ?P2) / ?[820.1 (1/n1) + (1/n2)] 
where P1 and P2 are the percent frequencies of the two groups being compared; n1 and n2 are 
respective sample sizes; and 820.1 is a constant representing the parametric variance of a 
distribution of arcsine transformations of percentages (Sokal and Rohlf, 1981).  The arcsine is 
the angle, in degrees, whose sine corresponds to the value given and was determined from 
published tables (Rohlf and Sokal, 1981).  The ts values were compared to critical values of 
Student’s t distribution using a two-tailed distribution.   
Results  
Characterization of the Rhesus Mitochondrial Common Deletion  
 To validate the assay for the detection of the rhesus common deletion, the nested PCR 
strategy shown in Table 1 and Figure 1 was employed.  Primers RhM15.1 and RhM15.6 were 
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used to amplify DNA isolated from skeletal muscle tissue of a 31 year old rhesus monkey.  A 
599bp internal positive mtDNA control was observed in duplicate (Figure 2; lanes 1 and 2).  The 
rhesus mitochondrial common deletion was amplified from the same tissue and showed a 180bp 
fragment (Figure 2; lanes 3 and 4).  DNA sequencing of the 180bp amplicon demonstrated that a 
5703bp deletion occurred in the rhesus mitochondrial genome.  Using a nested PCR reaction as 
described in materials and methods, the remaining 180bp amplicon is the result of the deletion of 
the 5703bp, as shown in Figure 1.    
 
Figure 2:  The rhesus common deletion was generated using DNA isolated from 31yr old rhesus 
skeletal muscle.  Nested PCR products were separated on 1.2% agarose gel and stained with 
ethidium bromide.  Lane M: 100 bp DNA Ladder.  Lane 1 and 2 demonstrate the internal control 
region amplified with primers RhM15.6 and RhM15.1 showing a 599 bp band.  Lanes 3 and 4 
show the rhesus common deletion 180 bp amplicon generated using primers RhM15.1 and 
RhM7.2 followed by RhM14.8 and RhM8966.  
Mitochondrial Deletions in Immature Oocytes 
Using the same nested PCR strategy, a total of 127 immature oocytes excised from 
necropsied ovaries (n=13 animals) were examined for the presence of the rhesus common 
deletion.  Only 27 of the 127 oocytes contained this deletion (21.3%).  The amplification 
efficiency was over 90%.  The intensity of the amplified PCR product varied, indicating different 
copy numbers of mtDNA among the oocytes analyzed.  Skeletal muscle tissue from a 31 year old 
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monkey served as a positive control and showed the same 180bp amplicon illustrated in Figure 2  
Mitochondrial Deletions in NHP Oocytes and Embryos  
 Using the same PCR amplification strategy, a total of 22 metaphase II (MII) oocytes (n=4 
animals), 17 oocytes that failed to fertilize (n=3 animals) and 31 day three embryos (n=6 
animals) were tested for presence of the common deletion.  Surprisingly, 77.3% of the stimulated 
MII oocytes, 70.6% of failed fertilized oocytes and 67.7% of the embryos harbored this mutation 
(Table 2).  Figure 3A (Lanes; 1-13) shows the positive mitochondrial control 599bp amplicon 
from each oocyte and embryo.  Figure 3B (Lanes; 1, 2, 4, 5, 6, 8, 9) shows the 180bp common 
deletion.  This mitochondrial deletion was not present in every oocyte and embryo in Figure 3B 
(Lanes; 3, 7, 6, 11, 12, 13).  There was a substantial difference in the band intensity of the 
common deletion in oocytes and embryos.  In addition, faint PCR products were observed with 
both the positive internal mitochondrial control primers and the nested primers. 
 
Table 2.  Detection of the mtDNA rhesus common deletion in rhesus oocytes and embryos by 
nested PCR.  
 Source   No. amplified mtDNA mtDNA Detected (%) 
  Deleted  Non-Deleted 
Necropsy oocytes        127 27  100 21.3a 
Stimulated oocytes    22 17 5 77.3b 
Stimulated UFOsc    17 12 5 70.6b 
IVF embryos    31 21  10 67.7b 
ab Statistically significant difference (P<0.001) by 2x2 G test and Students’ t-Test distribution.  A ratio of 
the number of rhesus common deletions amplified compared to the number of samples amplified indicates 
the amplification frequency.  cUFO = failed to fertilized oocyte. 
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Figure 3:  Rhesus control mtDNA and common deletion in rhesus gonadotrophin-stimulated 
oocytes and day 3 embryos. Lane M:  100 bp ladder. A) Lanes 1-6 demonstrates the internal 
control region amplified with primers RhM15.6 and RhM15.1 showing a 599 bp band in 
stimulated oocytes.  Lanes 7-13 show a 599 bp band control amplicon in IVF day 3 embryos. B) 
Lanes; 1, 2, 4, 5, 6,7, 8, 9 show the rhesus common deletion or 180 bp amplicon generated in 
stimulated oocytes or day 3 embryos using primers RhM15.1 and RhM7.2 followed by RhM14.8 
and RhM8966.  
Comparison of Non-Stimulated Oocytes and Stimulated Oocytes and Embryos that Harbor the 
Mitochondrial Deletions 
 In the non-stimulated oocytes, 21.3% (27/127) contained the mitochondrial common 
deletion compared with a frequency of 71.4% (50/70) in stimulated oocytes and embryos 
(P<0.001, Tables 2 and 3).  Additionally, there was a statistically significant difference 
(P<0.001) in the ratio of this mutation between non-stimulated oocytes and mature MII oocytes, 
embryos and oocytes that failed to fertilize, as a group. 
Discussion 
 Over 100 mitochondrial mutation associated diseases have been identified.  In addition, 
the accumulation of mtDNA deletions has been found in brain, cardiac muscle, skeletal muscle 
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and liver.  It was imperative that the initial mtDNA analysis be done using somatic tissue, such 
as skeletal muscle, as the comparative baseline for mtDNA candidates in monkey oocytes and 
embryos.  Skeletal muscle biopsies collected at 3-year intervals in rhesus macaques suggest that 
the increasing frequencies of mtDNA deletions are correlated with increasing age (Gokey et al., 
2004).  Specific Aim 1.1 of this study was to determine if the rhesus macaque can be utilized as a 
clinically translational model for mitochondrial mutations identified in human IVF.  In order to 
do this, a nested PCR strategy was applied using skeletal muscle from a 31 year old monkey.  
Analysis by PCR generated a 180bp PCR mtDNA fragment, rather than the 930bp amplicon 
observed in human mtDNA (Figure 2; lanes 3 and 4).  This indicates that the common deletion in 
rhesus monkeys entails the loss of 5703 base pairs, which is considerably larger than the 4977bp 
common deletion typically found in human KSS patients.  One reason for this discrepancy might 
be that the rhesus mitochondrial genome has only 80.4% nucleotide sequence homology with the 
human mitochondrial genome and may contain altered sites of preferential replication errors 
(Gokey et al., 2004).  Using the same nested PCR strategy shown in Figure 1, 127 immature 
oocytes and 70 stimulated oocytes and IVF embryos were evaluated for the rhesus mitochondria 
common deletion (Tables 2 and 3).  Through these data, we conclude that the rhesus macaque is, 
in fact, an excellent model to study mtDNA mutations found in human oocytes and IVF 
produced embryos.  
The second specific aim of this study was to determine if the rate of mitochondrial 
mutations in rhesus macaque oocytes and IVF produced embryos is increased due to 
gonadotrophin stimulation.  We found that the frequency of common mtDNA mutation in 
immature germinal vesicle (GV) oocytes excised from necropsied ovaries was low (21.3%) when 
compared with gonadotrophin-stimulated MII oocytes and embryos (71.4%).  The precise 
mechanisms responsible for this increase are unknown.  It has been suggested that there is a 
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massive amplification of the mitochondrial genome during the process of oogenesis, presumably 
to support the initial period of embryonic development.  The average mtDNA copy number of 
the human MII oocyte has been estimated to be 795,000 (+/- 243,000) (Barritt et al., 2002).  
However, it is not known whether the number of mtDNA molecules remains stable during 
primate preimplantation development.  It has recently been suggested that mitochondrial 
replication occurs during a very short period of time from the 1-to 2-cell stage in the mouse 
embryo prior to fertilization (McConnell and Petrie, 2004).  It is therefore unclear when 
mitochondrial transcription and replication actually begin in primate oocytes and embryos.  It has 
been shown that preimplantation mouse embryos are dependent upon the energy produced from 
mitochondria derived solely from the oocytes, and that mitochondrial replication does not occur 
until the blastocyst stage (Piko and Taylor, 1987; Smith and Alcivar, 1993).  In fact, the mtDNA 
copy numbers remain remarkably stable throughout preimplantation development.  Moreover, it 
has been reported that there is a high variability of mtDNA copy numbers among individual 
mouse blastocysts, suggesting that some embryos may be able to initiate mtDNA replication 
before implantation (Thundathil et al., 2005).  The increase in the mtDNA common deletion in 
stimulated rhesus MII oocytes and embryos shown here implies that mitochondrial replication 
may occur during either exogenous gonadotrophin stimulation, and/or during oocyte maturation 
in the rhesus macaque.  
The mechanisms that regulate mitochondrial replication and function during oogenesis 
and preimplantation development are largely unknown but are likely dependent on nuclear-
encoded factors, such as mitochondrial transcription factor (Tfam), nuclear respiratory factor 1 
(Nrf1), mitochondrial RNA polymerase (Polmt) and TFB1M and TFB2M.  It is unknown how 
mitochondrial replication processes might generate mitochondrial deletions and point mutations 
in aging tissues or non-dividing cells such as oocytes.  One theory is that ROS in the vicinity of 
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the mtDNA can cause both single-stranded and double-stranded breaks before Tfam binds to and 
stabilizes the mtDNA (Trifunovic et al., 2004). 
It has long been assumed that all of the mitochondria in the mature MII oocyte arise from 
the clonal expansion of an extremely small number of mitochondria during oogenesis, but it has 
never been determined precisely when these events take place (Van Blerkom, 2004).  Perhaps 
during the clonal expansion of these mitochondria, the rapidity of the replication process causes 
mtDNA defects.  Recent data show that oocyte ATP content increases significantly during 
porcine IVM similar to what has been reported in the cow (Brevini et al., 2005; Stojkovic et al., 
2001).  These data suggest that mitochondrial replication may also occur during porcine and 
bovine IVM.  
One explanation for the high frequency of mtDNA defects in oocytes from 
gonadotrophin-stimulated humans and monkeys (Barritt et al., 1999; Brenner et al., 1998; Chen 
et al., 1995; Keefe et al., 1995) and present study) is that administration of high doses of 
exogenous FSH recruits many more follicles than in a natural cycle, so that numerous defective 
oocytes that were destined for atresia are aspirated along with normal oocytes.  As a corollary, 
the proportion of oocytes with mtDNA defects increases in older primates because most of the 
“good” oocytes with normal mtDNA have already been recruited.  If this were true, then we 
would expect GV stage oocytes in unstimulated ovaries to contain a high incidence of mtDNA 
defects, which would not change much, if at all, following gonadotrophin stimulation.  However, 
our data contradict this explanation.  We found that the frequency of mtDNA defects (the 
common deletion) was relatively low (21%) in GV oocytes from unstimulated rhesus ovaries, but 
increased more than 3-fold (71%) in oocytes from follicles recruited using FSH stimulation.  
This result suggests that potentially the administration of exogenous FSH causes the mtDNA 
defects in oocytes.  It is very unlikely that the answers can be found from human clinical data 
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because of the inherent priority to obtain pregnancy rather than to examine different 
gonadotrophin stimulation approaches.  Instead, the etiology of mtDNA defects in primate 
oocytes must be examined using NHP, such as the rhesus monkey, in which experiments can be 
designed to specifically evaluate possible effects of gonadotrophin stimulation on oocyte quality 
and competence.  Such experiments are in progress in our laboratory to determine if extensive 
mitochondrial damage occurs during gonadotrophin stimulation and if this damage can be 
repaired via the nuclear mitochondrial transcription factor polymerase gamma (PolG) during 
early primate embryo development. 
 
Figure 4:  Rhesus mtDNA control and common deletion in non-stimulated germinal vesicle 
(GV) oocytes.  Lane M:  100 bp DNA Ladder.  A) Lanes 1-12: 590 bp mtDNA amplified with 
primers RhM15.1 and RhM15.6.  B) Lanes 1-12 show that no PCR amplicons were generated in 
the same oocytes using primers RhM15.1 and RhM7.2 followed by RhM14.8 and RhM8966.  
*NOTE:  Please see publication of this work for further detail (Gibson et al., 2005).  
 
Table 3.  Frequency of the mtDNA rhesus common deletion in stimulated oocytes and embryos 
vs. non-stimulated oocytes. 
 No. amplified mtDNA mtDNA   Detected (%) 
   Deleted Non-Deleted 
Non-Stimulated  127 27 100 21.3a 
Stimulated 70 50   20 71.4b 
ab Statistically significant difference (P<0.001) by 2x2 G test and  Students’ t-Test distribution.  A ratio of 
the number of rhesus common deletions amplified compared to the number of samples amplified indicates 
the amplification frequency. 
40 
 
 
CHAPTER 3 
SPECIFIC AIM 2 
Introduction 
Specific Aim 2: Due to the frequency of the rhesus mtDNA common mutation in 
gonadotrophin stimulated, rhesus macaque MII oocytes and IVP embryos, we hypothesize 
that the common mutation will also be present in embryonic stem (ES) cells derived from 
IVP produced embryos. 
Numerous laboratories have detected a specific mtDNA mutation, known as the common 
deletion (?mtDNA4977), in human oocytes and IVP embryos at a frequency of 30% to 50% 
(Barritt et al., 1999; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995).  These oocytes 
and embryos were obtained from infertile patients.  Our laboratory has recently reported that the 
rhesus mitochondrial common deletion is present in fertile rhesus macaque oocytes and embryos 
(Gibson et al., 2005).  Oocytes from necropsied ovaries of rhesus macaques show that the 
common deletion naturally occurs in 21% of GV oocytes (Gibson et al., 2005).  Gonadotrophin 
stimulation increases the frequency of this deletion to 77% in MII oocytes, and 68% in day three 
IVP embryos (Gibson et al., 2005).  These results imply that the administration of exogenous 
FSH may induce mtDNA defects in oocytes, embryos and their subsequent embryonic stem cell 
derivatives. 
It is widely known that production of embryonic stem cell lines from the inner cell mass 
(ICM) of blastocysts is difficult and incurs considerable expense.  At present, 18 rhesus macaque 
ES cell lines have been produced.  Ten of these lines are derived from IVP blastocysts (ORMES 
series) and eight from in vivo produced blastocysts (R series) flushed from the uteri of monkeys 
after artificial insemination (Pau and Wolf, 2004).   
Given that mtDNA mutations are present in gonadotrophin stimulated, rhesus macaque 
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MII oocytes and IVP embryos, it can reasonably be inferred that such defects also persist in the 
ES cells derived from them.  Thus, the presence of numerous mtDNA deletions and point 
mutations may actually reflect the quality of affected oocytes or primate ES cells lines.  Primate 
ES cell lines may harbor mutant mtDNA that may further accumulate during cell culture, and 
thus have consequences for long-term viability.  Therefore, one objective of this study was to 
determine the prevalence of the rhesus mitochondrial common deletion in ES cells.  Future 
medical applications of stem cell therapies include the use of cells originating not only from 
embryos but also from adult tissues (Bavister et al., 2005).  Therefore, we investigated whether 
the common mitochondrial mutation was present in multiple passages of an adult bone marrow 
stromal stem cell line (BMSC).  Finally, mtDNA from an adult adipose stromal stem cell line 
(ATSC) was compared with mtDNA from ATSC-TERT, the same line immortalized through 
transfection with a retroviral vector expressing telomerase. 
Material and Methods 
Animals 
All animal procedures conformed to the requirements of the Animal Welfare Act and 
protocols were approved before implementation by the Institutional Animal Care and Use 
Committee (IACUC) of Tulane University and the Oregon National Primate Research Center. 
DNA Extraction and PCR Analysis 
To detect the rhesus common deletion, a nested PCR strategy was applied.  Total cellular 
DNA, from TERT-ATSCs (passages (p) 10 and 20); ATSCs (p11 and 16); BMSCs (p1, 10, 20 
and 30); as well as the ES cell lines ORMES 1 (p21), 2 (p11), and 7 (p24); and R4 (p20), was 
isolated using the Puregene Genomic DNA kit (Gentra Systems, Minneapolis, MN, USA).  The 
gene-specific oligonucleotide primers used in this study were synthesized by Sigma Genosys 
(The Woodlands, TX, USA).  Using a MyCycler Thermal Cycler (Bio-Rad, Hercules, CA, 
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USA), each sample was amplified in a 25 µl reaction volume containing 100 ng of DNA, 1.5 
mM MgCl2, 1 IU Taq polymerase, 200 µM each dNTP, and 0.5 µM gene-specific primers.  For 
all cell lines, the following amplification profile was used: 1 cycle of 95°C for 1 min; 30 cycles 
at 95°C for 25 sec, 62°C for 25 sec and 72°C for 2 min; followed by 1 cycle at 72° C for 5 min; 
and a hold at 4°C.  For the nested PCR, 2µl of the first reaction served as a template.  The nested 
PCR was performed using the following profile: 1 cycle of 95°C for 1 min; 40 cycles at 95°C for 
25 sec, 62°C for 25 sec then 72°C for 2 min; followed by 1 cycle at 72° C for 5 min; and a hold 
at 4°C.  Duplicate PCR reactions were performed for each sample as well as a genomic GAPDH 
control for assessing PCR efficiency.  The detection of all PCR results was detected by agarose 
gel electrophoresis, and stained with ethidium bromide 
PCR Detection of the Rhesus Common Deletion 
Oligonucleotide primers used for amplification of the target sequences of mtDNA and 
corresponding human mtDNA positions have been previously published (Gibson et al., 2005).  
Primers for rhesus GAPDH were: GAPDH forward ACCACCATGGAGAAG GCTGG; and 
GAPDH reverse TCAGTGTAGCCCAGGATGC, resulting in a 528bp DNA product after PCR 
amplification. 
Results 
Mitochondrial Deletions in NPH Oocytes and Embryos  
 Using a nested PCR amplification strategy (Gibson et al., 2005), all samples amplified a 
599bp amplicon as a positive mtDNA control (Figure 5A).  A high proportion of rhesus macaque 
MII oocytes and day 3 IVP embryos were found to harbor the rhesus mitochondrial common 
deletion (Figure 5B).  Over 75% of MII oocytes (n=22) and greater than 65% of IVP embryos 
(n=31) harbored this mutation.  Furthermore, differences in intensity of the common deletion 
amplicon were detected among individual oocytes and embryos. 
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Figure 5:  Rhesus control mtDNA and the common deletion in rhesus gonadotrophin-stimulated 
oocytes and day 3 embryos.  Lane M:  100 bp ladder.  Figure 1A, Lanes 1-3 demonstrate the 
internal control region showing a 599 bp amplicon in stimulated oocytes.  Lanes 4-6 in 1A show 
a 599 bp band control amplicon in day 3 IVF embryos.  Figure 1B, Lanes 1-3 show the rhesus 
common deletion, a 180 bp amplicon generated in stimulated oocytes.  Lanes 4-6 in 1B show the 
common deletion generated in day 3 IVP embryos. 
Mitochondrial Deletions in NHP ES Cell Lines 
 Using nested PCR, the rhesus mitochondrial common deletion was detected in all three 
IVP ESC lines; ORMES 1 (p21), 2 (p11) and 7 (p24), as well as from the R4 (p20) cell line, a 
rhesus ES cell line derived from an in vivo produced embryo (Figures 6 and 7, respectively).  
DNA sequencing of the 180bp amplicon (Figure 6, Lanes 2, 5 and 8; Figure 7, Lanes 3 and 4) 
demonstrated that it corresponded to the 5703bp deletion in the rhesus mitochondrial genome, as 
previously shown (Gibson et al., 2005).  This mtDNA deletion corresponds to the same deletion 
found in rhesus macaque oocytes and day 3 embryos (Figure 5B).  To confirm the presence of 
both mitochondrial and genomic DNA, a 599bp internal control (Figure 6, Lanes 1, 4 and 7; 
Figure 7, Lanes 1 and 2) and a 528bp rhesus GAPDH (Figure 6, Lanes 3, 6 and 9) were 
amplified and detected. 
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Figure 6:  Rhesus control mtDNA, common deletion and genomic GAPDH in 3 in vitro derived 
ES cell lines ORMES 1, 2, and 7.   Lane M: 100 bp ladder.  Lanes 1, 4, and 7 demonstrate the 
internal control region showing a 599 bp amplicon in lines 1, 2 and 7, respectively.  Lanes 2, 5 
and 8 show the rhesus common deletion, a 180 bp amplicon generated in lines 1, 2, and 7, 
respectively.  Lanes 3, 6 and 9 show a genomic GAPDH control, a 528 bp amplicon generated in 
lines 1, 2 and 7, respectively. 
 
 
 
 
Figure 7:  Rhesus control mtDNA and common deletion in the in vivo derived ES cell line R4.  
Lanes M:  100 bp ladder.  Lanes 1 and 2 demonstrate the internal control region showing 
duplicate 599 bp amplicons.  Lanes 3 and 4 show the rhesus common deletion, duplicate 180 bp 
amplicons. 
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Figure 8:  Rhesus control mtDNA and common deletion in the TERT-ATSC and the ATSC cell 
lines.  Lane M: 100 bp ladder.  A) Lanes 1, 2, 5 and 6 demonstrate the internal control region 
showing duplicate 599 bp amplicons from the TERT-ATSC cell line in passages 10 and 20, 
respectively.  Lanes 3, 4, 7 and 8 show the rhesus common deletion, a very faint duplicate 180 bp 
amplicons from the TERT-ATSC cell line in passages 10 and 20, respectively.  B) Lanes 1, 2 and 
5 demonstrate the internal control region showing a 599 bp amplicon in duplicate (lanes 1 and 2) 
and a single replicate (lane 5) from the ATSC line, passages 11 and 16, respectively. Lanes 3, 4 
and 6 show the rhesus common deletion, a 180 bp amplicon in duplicate (lanes 3 and 4) and a 
single replicate (lane 6) from the ATSC line, passages 11 and 16, respectively. 
Detection of the Rhesus Common Deletion in Adult Stem Cells  
A non-human primate adipose stromal cell line (ATSC), a telomerase induced adipose 
stromal cell line (TERT-ATSC) and a bone marrow stromal cell line (BMSC) were examined for 
the mtDNA common mutation.  Interestingly, the TERT-transfected ATSCs grew continuously 
and the rhesus common mitochondrial mutation was only faintly detected, regardless of passage 
number (Figure 8A, Lanes 3, 4, 7, and 8).  Non-transfected ATSC cells harbored the mtDNA 
mutation at passages 11 and 16 (Figure 8B, Lanes 3, 4 and 6).  The BMSC cell line showed high 
levels of mitochondrial mutations in passages 3, 10 and 30 (Figure 9, Lanes 3, 4, 7, 8, 11 and 
12).  Both the internal control (see Figure Legends 8 and 9) and genomic GAPDH (data not 
shown) were detected in all adult stem cell lines. 
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Figure 9:  Rhesus control mtDNA and common deletion in the BMSC cell line.  Lane M: 100 bp 
ladder.  Lanes 1, 2, 5, 6, 9 and 10 demonstrate the internal control region showing duplicate 599 
bp amplicons in passages 3 and 10 and 30, respectively.  Lanes 3, 4, 7, 8, 11 and 12 show the 
rhesus common deletion, duplicate 180 bp amplicons in passages 3, 10 and 30, respectively. 
(*NOTE:  Please see Appendix B for this publication.  (Gibson et al., 2006)) 
Discussion 
This is the first study to examine mtDNA mutations in embryonic and adult NHP stem 
cell lines.  In conjunction with our previous report (Gibson et al., 2005), it is now clear that 
mtDNA mutations are detectable in oocytes, embryos, adult and ES cells from fertile rhesus 
macaques.  Over 60% of oocytes and embryos from gonadotrophin stimulated monkeys contain 
mitochondrial deletions, which carried into ES cell derivatives.  It is likely that repeated 
passaging of ES cell lines derived from these oocytes increases the occurrence of deletions that 
may eventually render the cells metabolically impaired and, as a result, lead to developmental 
incompetence (Bavister et al., 2005), although this remains to be determined. 
Increasing accumulation of mtDNA mutations may be linked to aging, which has been 
associated with functional competence of stem cells through changes in the activity of 
telomerase, the reverse transcriptase that elongates telomeres.  Transfection of the catalytic 
subunit of telomerase, TERT, extends the lifespan of the transfected cell line, thus preventing 
senescense (Flores et al., 2005; Kang et al., 2004).  In the present study, mtDNA from an adipose 
stromal cell line (ATSC) was compared with mtDNA from an immortalized (ATSC-TERT) cell 
line.  Interestingly, the presence of the common deletion in the ATSC-TERT cell line was 
diminished compared with levels exhibited in the control (non-transfected) ATSC cell line 
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(Figure 8).  Similarly, adult bone marrow stromal stem cells (BMSC) showed high levels of the 
rhesus mtDNA common deletion, regardless of passage (Figure 9).  Furthermore, ongoing 
studies are in progress to determine whether additional deletions and point mutations are present 
in representative primate stem cell lines. 
Disruption of ATP production in stem cell lines may not only alter cell division rates, but 
may also be related to premature apoptosis, mitochondrial disorders, the accumulation of 
chromosomal abnormalities such as aneuploidies, and early differentiation or possible failure to 
differentiate (Barnett et al., 1997; Chinnery et al., 2004; Eichenlaub-Ritter et al., 2004; 
McConnell and Petrie, 2004; Van Blerkom et al., 2000; Van Blerkom et al., 1995a).  Preliminary 
results from our laboratory also indicate that mitochondrial properties, such as ATP production, 
may change in adult stem cell lines, supporting the results reported in the present study that adult 
stem cell lines may harbor defects in mitochondrial integrity and function (Lonergan, 
unpublished results).  It has also been proposed that functional mitochondrial defects could also 
result from the asymmetric distribution of mitochondria during cell division, leading to 
disproportionate mitochondrial inheritance and a subsequent diminished ATP-generating 
capacity (Van Blerkom et al., 2000; Van Blerkom et al., 1995b). 
The successful use of stem cell lines for therapeutic cell replacement or for drug 
development and testing will require that cells exhibit physiological and molecular stability over 
extended periods of culture.  If stem cell lines accumulate mtDNA mutations with increased time 
in culture, the functional competence of these lines may be compromised.  Our results, as well as 
others (Maitra et al., 2005), indicate that the characterization of mtDNA mutations in both non-
human primate and human cell lines has important implications for establishing the normality of 
cell lines prior to use in future studies.  A strong argument has previously been presented for the 
detailed characterization of NHP stem cell lines (Bavister et al., 2005). 
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At this time, there are no established molecular and cellular markers to ascertain which 
cell lines are defective or functionally competent.  The key question is what functional 
characteristics, important for normal differentiation of these cell lines, should be used to select 
the most normal lines for further in-depth studies, particularly prior to organ and tissue 
derivation for use in human ES cell technologies?  It is of concern that mtDNA mutations are 
found in a wide spectrum of cancers and aging tissues (Wallace, 2005).  The possibility remains 
real that the use of aberrantly developing stem cells for therapeutic cell replacement could lead to 
the development of cancer.  NHP ES cells, created from presumptively normal blastocysts, are 
derived from oocytes of young, fertile monkeys.  However, results of the present study show that 
regardless of their origin, i.e., the in vivo derived cell line (R4) and the ES cell lines generated 
from IVP embryos, all lines exhibited the common deletion (Figures 6 and 7).  These results 
suggest that the culture conditions under which the cell lines are maintained, or the derivation 
process, may alter the occurrence of this and possibly other deletion(s).  However, whether the in 
vivo derived embryos exhibit the common deletion prior to generation of the stem cell line still 
needs to be determined. 
It is clear from the present study that the existing stem cell lines, whether generated from 
in vitro or in vivo derived embryos, are not suitable for therapeutic purposes and perhaps not for 
drug testing.  However, their characterization will enable identification of other useful stemness 
markers.  It remains to be determined which lines should be selected for: (i) the development of 
improved, controlled culture conditions, free from serum and mouse feeder cell layers so that ES 
cells can be more reliably maintained in the undifferentiated state with karyotypic and 
mitochondrial stability; (ii) elucidation of control factors, (i.e., specific alterations to the culture 
milieu), growth factors, hormones, etc., to direct differentiation into derivative cell types and 
tissues; and (iii) comparisons of early versus late passage cells to establish mitochondrial 
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stability in prolonged culture.  These studies will be considerably costly and time consuming.  It 
is therefore imperative to select the best ES cell lines to be used as the starting material before 
committing major resources. 
Mechanisms that regulate mitochondrial function during oogenesis and preimplantation 
development are largely unknown but are likely dependent upon nuclear-encoded mitochondrial 
transcription factor (Tfam), nuclear respiratory factor 1 (Nrf1), mitochondrial RNA polymerase 
(Polmt) and mitochondrial transcription factor B1 (Tfb1m) and B2 (Tfb2m).  It is currently 
unknown how mitochondrial replication processes might generate mitochondrial deletions and 
point mutations in aging tissues or non-dividing cells, such as oocytes.  Double stranded breaks 
may actually occur during the mitochondrial replication process.  Furthermore, the DNA helicase 
(Twinkle) or replication stalling caused by mutations in polymerase gamma (PolG) may be 
partially responsible for these replication malfunctions.  DNA PolG is required for both 
replication and repair of mtDNA.  It has been shown that homozygous knock-in mice lacking 
PolG's exonuclease function harbored deletions and mutagenesis of mtDNA with a premature 
aging phenotype (Trifunovic et al., 2004).  In further studies, we plan to investigate the 
molecular control of mitochondrial transcription and replication during IVP production of 
preimplantation embryos (Pei and Brenner, unpublished results).   
We have shown that the common deletion occurs naturally in the rhesus oocyte; that the 
prevalence of this mutation is dramatically increased by gonadotrophin stimulation; and that 
there is continued presence of the deletion in the day 3 IVP embryo.  Due to the existence of this 
same mutation in all 3 IVP derived ES cell lines examined, out of the 10 existing lines, it is 
logical to extrapolate that many, if not most, NHP ES cell lines may harbor this mutation.  The 
rhesus common deletion was also found in two adult stromal stem cell lines.  Additionally, in the 
presence of a subunit of telomerase known to extend the lifespan of cells, the occurrence and/or 
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replication of the mutation is limited.  In both non-human primate and human stem cell lines, it is 
currently unknown what mutations exist and to what extent.  It is imperative that ES cell lines be 
further characterized and that culture improvements be made.  NHP ES cells present a valuable 
alternative to human ES cells in order to address issues of safety and efficacy of transplanted 
organs and tissues in NHP before any such clinical studies should be allowed in humans.   
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CHAPTER 4 
SPECIFIC AIM 3 
Introduction 
Specific Aim 3.1: To determine if increases in the presence of mutations in the mtDNA 
control region, as well as the mitochondrial polymerase, PolG, are associated with aging in 
the rhesus macaque. 
Specific Aim 3.2: To determine if increases in the presence of mutations in the mtDNA 
control region are associated with meiotic failure in oocytes.  
It is thought that progressive damage to mtDNA during life contributes to the aging 
process. Mitochondrial DNA rearrangements accumulate with age and become predominant in 
post-mitotic, non-dividing tissues (Cortopassi and Arnheim, 1990).  Similarly, in aging rhesus 
macaques, high levels of mtDNA deletions can accumulate in skeletal muscle (Schwarze et al., 
1995).  It has been shown that up to 50% of individuals over 65 years of age exhibit a T to G 
transversion at a base pair position (414) within the mitochondrial control region that was absent 
in younger individuals (Michikawa et al., 1999); as well as two other muscle-specific mutations 
that accumulate with age in the critical human mitochondrial control region (Wang et al., 2001). 
The tissues most commonly affected by mtDNA mutations and subsequent disorders are those 
that are normally affected by aging, i.e. brain, heart, skeletal muscle, kidney and the endocrine 
system (Wallace, 2005).  It has been shown that there is a correlation between aging and the 
presence of the mitochondrial common deletion in skeletal muscle, however, to date mutations in 
the mtDNA control region have not been investigated. As previously stated, the mtDNA control 
region contains the origin of replication of the heavy strand, two initiation sites for transcription 
of the heavy strand mtDNA, the promoter for transcription of the light strand, and the primary 
and secondary initiation sites for heavy strand synthesis.  In order to examine potential age 
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associated effects in skeletal muscle, we have established distinct age groups in the rhesus 
macaque that correlate to human reproductive ages.  We compared the mtDNA control region 
sequences to a known rhesus macaque mtDNA sequence in order to determine if there were any 
significant changes associated with age.   
One primary difference between nuclear DNA and mtDNA are the replication repair 
mechanisms present in the two genomes.  It has been determined that the spontaneous mutation 
rate in mtDNA is more than two orders of magnitude higher than what is typically observed in 
nuclear DNA (Khrapko et al., 1997).  Mitochondrial DNA do not have histones and there is only 
one known repair mechanism, the 3’-5’ exonuclease function that is part of the only known 
mitochondrial polymerase, PolG.  It is widely thought that the limited repair function is 
responsible for the high mutation rate seen in mtDNA.  It has been shown that when the  
catalytic subunit of the mitochondrial polymerase, PolG, is knocked out it results in embryonic 
lethality in mouse embryos which causes early developmental arrest between embryonic days 7.5 
and 8.5, associated with severe mtDNA depletion (Hance et al., 2005).  Additionally, when 
homozygous knock-in mice that expressed a proof-reading-deficient version of PolGA, the 
catalytic subunit of PolG, were created, the mice developed an mtDNA mutator phenotype with a 
3-5 fold increase in the levels of point mutations, as well as increased amounts of deleted 
mtDNA (Trifunovic et al., 2004).  This increase in somatic mtDNA mutations is associated with 
reduced lifespan and premature onset of age-related phenotypes (Trifunovic et al., 2004).  
Considering how critical PolG is to mtDNA replication, we felt it was important to determine if 
mtDNA mutations in the catalytic subunit of PolG, as well as the region of such importance 
identified by Trifunovic et. al., are present in the same skeletal muscle samples used to determine 
if there are age related mutations in the mtDNA control region.   
 The final aim of this study was to determine if meiotic arrest of NHP oocytes is 
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correlated to mutations within the mtDNA control region.  It has been proposed that in oocytes 
and preimplantation embryos accumulation of mtDNA mutations in the mitochondrial genome 
contributes to impaired metabolic function and thus to developmental incompetence (Barritt et 
al., 1999; Barritt et al., 2000b; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995).  
Oocytes have large numbers of mitochondria, as discussed Chapter 1, that can support essential 
developmental processes such as oocyte growth and meiotic maturation.  When tissues 
accumulate mtDNA rearrangements that reach a clinically significant threshold, the efficiency of 
oxidative phosphorylation is reduced (Cortopassi and Arnheim, 1990).  It is generally assumed 
that there needs to be a sufficient number of normal mitochondrial genomes in order for the 
oocyte to mature and the subsequent embryo to develop and implant; however, a relationship 
between mitochondrial mutations and reproductive success is unproven.  Therefore, we wanted 
to determine whether there is an increasing percentage of mtDNA mutational load within the 
control region corresponding to failure of oocytes to complete metaphase II of meiosis, enabling 
them to be fertilized and poor embryo development. 
We compared mtDNA control region sequences from arrested GV, arrested MI, normal 
MII oocytes and preimplantation embryos within and among cohorts for mutations that may be 
causing meiotic arrest and poor embryo quality.    
Materials and Methods  
Experiment 1 
Collection of material 
Initially, we established age groups in which all animals were assigned: 1) <5 (juvenile), 
2) 6-10 (early reproductive), 3) 11-20 (late reproductive) and 4) ?21 (aged).  These age groups 
were selected as they correlate to human reproductive ages.  Establishment of these groups 
enabled us to examine any age effects that may be occurring during the aging process.  The 
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rhesus macaque mtDNA control region, including the D-Loop, is approximately 1100bp long.  
MtDNA control region specific primers were designed and synthesized by Sigma Genosys (The 
Woodlands, TX, USA).  Rhesus macaque skeletal muscle was collected by necropsy and flash 
frozen in liquid nitrogen (LN2).  Total DNA was extracted using a Puregene DNA purification 
system (Gentra, Minneapolis, MN, USA).  Mitochondrial specific primers were used to detect 
the mtDNA control region, PolG catalytic subunit and PolG Exon 3.  PCR reactions contained 
100ng of total DNA in a 50µl reaction containing 1X Taq PCR buffer, 2.0mM MgCl2, 200µM 
each dNTP, 0.5µM each forward and reverse primers and 1.25U Taq DNA polymerase.  PCR 
products were then submitted for direct sequencing.  All sequences were performed using the 
BigDye Terminator sequencing reactions, purification and the analysis system by Applied 
Biosystems. 
Experiment 2 
Controlled Hormonal Ovarian Stimulation 
The ovarian stimulation protocol has been previously described (Zelinski-Wooten et al., 
1995). Briefly, rhesus macaques were hormonally stimulated with a sequential regimen of 
recombinant human gonadotrophins at either the Oregon National Primate Research Center 
(ONPRC) and the Caribbean Primate Research Center (CPRC).  Female rhesus macaques at the 
ONPRC received rFSH (Organon, Oss, The Netherlands; 30 IU per injection, twice daily, IM) 
for 7 days, followed by 2 days of rFSH and rLH (EMD Serono, Rockland, MA; 30 IU rFSH and 
30 IU rLH per injection, twice daily, IM).  During the final 3 days of the rFSH treatment, 
animals also received the GnRH antagonist Acycline (0.075 mg/kg animal body weight) to 
prevent a spontaneous LH surge. Ovarian stimulation of rhesus macaques at the CPRC was 
performed by administration of rFSH (Organon, Roseland, NY; 37.5 IU per injection, twice 
daily, IM) for 10 days. At both primate centers, on the final day of rFSH treatment, 32–33 hours 
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before follicular aspiration, oocyte maturation was induced with a single injection of 
recombinant hCG (750–1,000 IU, IM). 
Oocyte and Sperm Collection, Insemination, and Embryo Culture 
Procedures for oocyte recovery, sperm collection, insemination, and embryo culture have 
been described previously (Bavister et al., 1983a; Boatman and Bavister, 1984; Wolf et al., 
1989).  Briefly, follicular fluid was collected in TALP-HEPES containing 0.3% bovine serum 
albumin (BSA).  The aspirates were sifted through a cell strainer and oocytes were collected after 
rinsing the filter.  After cumulus removal using hyaluronidase (0.03%), oocytes were rinsed, 
meiotic stage was determined (GV, MI or MII) and placed in these groups in TALP medium 
culture drops supplemented with BSA, (Bavister and Yanagimachi, 1977), and incubated in 5% 
CO2 in air at 37°C.  GV, MI and half of the cohort of MII oocytes were stripped of their zonae 
pellucidae with acid Tyrode’s solution (Sigma-Aldrich, St. Louis, MO, USA).  They were 
individually placed into 0.2 ml PCR tubes with 3 ?l of 0.1% polyvinyl alcohol (PVA) in 
phosphate buffered saline (PBS).  Samples were stored at -20°C until use. Semen was obtained 
by electroejaculation (Mastroianni and Manson, 1963) and seminal plasma was removed 
according to standard protocols. Spermatozoa were activated with dbcAMP and caffeine (1 mM 
each) and used for insemination of the remaining MII oocytes at a final concentration of 1.5–
2.0×105 sperm/mL.  The presence of pronuclei was assessed 18–20 hours after insemination.  
Presumptive zygotes were transferred to amino acid-supplemented HECM-9 culture drops 
(McKiernan and Bavister, 2000) and incubated under a 5% CO2 in air atmosphere at 37°C until 
day 3. Approximately 72hrs post insemination embryos were frozen in the same manner as the 
rest of the cohort of oocytes.  
Embryos and oocytes (denuded of cumulus cells using 10mg/ml hyaluronidase dissolved 
in TL-HEPES) were stripped of their zonae pellucidae with acid Tyrode’s solution (Sigma-
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Aldrich, St. Louis, MO, USA).  They were individually placed into 0.2 ml PCR tubes with 3 ?l 
of 0.1% polyvinyl alcohol (PVA) in phosphate buffered saline (PBS).  Samples were stored at -
20°C until use.  Prior to PCR, 3 ?l of a mixture of 4x10-4 M sodium dodecyl sulfate (SDS; 
Sigma-Aldrich) and 125 ?g/ml proteinase K (Roche Diagnostics Corp, Indianapolis, IN, USA) 
were added to each tube for cell lysis.  The tubes were incubated at 37°C for 1 hr, and then 
heated to 95°C for 15 min to inactivate proteinase K.   
The gene-specific oligonucleotide primers used in this study were synthesized by Sigma 
Genosys (The Woodlands, TX, USA).  To amplify the internal control mtDNA region and the 
rhesus common deletion simultaneously, the DNA was divided into two 3?l aliquots prior to 
PCR amplification.  Each aliquot was amplified using a MyCycler Thermal Cycler (Bio-Rad, 
Hercules, CA, USA) in a 25 ?l reaction volume containing 1.5 mM MgCl2, 1 IU Taq 
polymerase, 200 ?M each dNTP and 0.5 ?M gene-specific primers using the following 
amplification profile for all reactions (annealing temperature specific for each primer pair): an 
initial denaturation of 95ºC for 2 min, followed by 30 cycles of 95ºC for 30s, annealing for 30s 
and primer extension for 1min at 72º C, with a final extension of 72ºC for 5min.  PCR products 
were then submitted for direct sequencing.  All sequencing was performed using the BigDye 
Terminator sequencing reactions, purification and the analysis system by Applied Biosystems.   
Sequence Analysis 
Sequence analysis was performed on all rhesus macaque skeletal muscle, oocytes and 
embryos from IVP.  Only sequences with a quality of Q20 or greater were used for analysis.  For 
control region and PolG sequence analysis, consensus sequences were created for each skeletal 
muscle sample for both regions of interest.  For oocyte and embryo sequence analysis, consensus 
sequences were created for each animal and oocyte group, (i.e. Animal 18879 GV) and 
compared to each other and the mtDNA control region of the Macaca Mulatta mitochondrion 
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complete genome (NCBI Accession AY612638) using Sequencher Software by Gene Codes Inc.  
Results 
Rhesus Macaque Skeletal Muscle Sequencing 
A total of 18 rhesus macaque skeletal muscle samples were collected and assigned to 
each of the four age groups: 1(n=7), 2(n=4), 3(n=4) and 4(n=3).  Due to the limited number of 
aged animals in captivity, group 4 had the lowest number of samples available. MtDNA 
consensus sequences from both skeletal muscle and reproductive material were compared to the 
mtDNA control region of the Macaca Mulatta mitochondrion complete genome (NCBI 
Accession AY612638) and to each other.  One area within the mtDNA control region became an 
area of interest once all samples were compared.    
 
Figure 10: Region of interest within the mtDNA control region.  All sequences are identified by 
the age of the animal at the time of death and aligned to control sequence.  
From mtDNA nucleotides 251-252 insertion of an ACACC repeat ranging from 1-5 
repeats were found in 5 samples (Figure 10).  This region corresponds to the H-Strand promoter 
region and a TFAM binding site.  This insertion was seen in three samples in age group 1, one 
sample in age group 2 and one sample in age group 4 (Table 4).  There was no correlation 
between advanced aging and this insertion.  In fact, three out of seven samples in the youngest 
age group (group 1) were found to harbor this insertion (Table 4).  The muscle sample from the 
58 
 
 
29 y.o. animal had an extremely high rate of point mutations, insertions and deletions (Appendix 
1).   
Table 4: Number of skeletal muscle samples analyzed in each of the four age groups and number 
of samples that exhibited the insertion in the TFAM binding site in each of the four age groups. 
 Group 1 Group 2 Group 3 Group 4 
# samples 7 4 4 3 
# samples with insertions 4 1 0 1 
All 18 skeletal muscle samples analyzed for mtDNA control region inserts were also 
analyzed for mutations within the catalytic subunit of the mitochondrial polymerase, PolG.  We 
found no consistently exhibited mutations in the catalytic subunit and no correlation between 
advance age and accumulation of mutations (Appendix 2).   
Rhesus Macaque Oocyte and Embryo Sequencing 
Oocytes from 5 rhesus IVF cycles and embryos from 2 rhesus IVF cycles were analyzed 
(Table 5). 
We found no correlation between meiotic arrest during oocyte maturation and mtDNA 
control region mutations (Appendix 3).  We believe the lack of correlation between aging and 
oocyte maturation to mtDNA control region mutations indicates there are other factors 
influencing the aging phenotype as well as meiotic arrest during oocyte maturation. 
Table 5: Number of oocytes and embryos sequenced from each animal.  
 18879 19733 21129 21176 22031 Total 
GV - 7 3 - - 10 
MI - 8 5 4 3 20 
MII 5 7 5 4 5 26 
Day 3 Embryos - 8 4 - - 12 
Discussion  
 The purpose of this specific aim was threefold: 1) to determine if there are mutations in 
the mtDNA control region associated with the aging phenomenon, 2) to determine if there are 
mutations in the catalytic subunit of the mitochondrial polymerase, PolG, associated with aging, 
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and 3) to determine if there are mutations in the mtDNA control region associated with failure of 
oocytes to resume meiosis and develop to a fully mature state, (MII), enabling them to be 
fertilized.  We sequenced the mtDNA control region of 18 rhesus macaque skeletal muscle 
samples from animals ranging in age from 1-31 year.  We found no correlation between aging 
and the accumulation of mtDNA point mutations within the mtDNA control region.  One muscle 
sample from an aged animal (29 y.o.) that we analyzed did contain numerous deletions, 
insertions and point mutations within the mtDNA control region (Appendix 1).  This sample was 
from the same 29 year old male rhesus macaque that was analyzed by Gokey (Gokey et al., 
2004).  They too found that this animal contained numerous mtDNA breakpoints and deletions 
throughout the mtDNA genome.  However, we also analyzed 2 other skeletal muscle samples 
from aged animals (31 y.o. and 21 y.o.) and found no point mutations in common with the 29 
y.o.  This indicated that point mutations and mtDNA control region deletions can accumulate 
with age, however it may be due to susceptibility of the individual animal and not due to the 
aging phenomenon.  This hypothesis is supported by the fact that three out of seven samples 
analyzed that were from animals under 5 years of age showed multiple insertions and point 
mutations within the same region (bp 251-252), to those seen in the sample from a 29 y.o. animal 
(Appendix 1).  These animals may have been susceptible to mtDNA damage from a very young 
age and therefore likely would have accumulated more mutations as they aged due to clonal 
expansion of mutant mtDNA genomes, not necessarily due to the aging process causing mtDNA 
damage over time. 
We sequenced the catalytic subunit of the mitochondrial polymerase, PolG, of all 18 
samples sequenced for the mtDNA control region.  PolG is encoded in the nucleus and contains 
two subunits: a large catalytic subunit that harbors the 3’-5’ exonuclease and 5’deoxyribose 
phosphate (dRP) lyase activities, and a smaller accessory subunit which increases both the 
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catalytic activity and processivity of the catalytic subunit.  Diseases such as PEO, KSS, Alpers 
syndrome and ataxia, as well as symptoms of premature menopause, progressive muscle 
weakness, parkinsonism, and male infertility are coupled with mutations in human PolG (Luoma 
et al., 2004; Mancuso et al., 2004; Naviaux and Nguyen, 2004; Van Goethem et al., 2001; 
Zeviani et al., 1988; Zeviani et al., 1989).  Two particular studies led us to examine the catalytic 
subunit of PolG in the rhesus.  First, Trifunovic found that homozygous knock-in mice that 
expressed a proof-reading-deficient version of the catalytic subunit of PolG developed an 
mtDNA mutator phenotype with a 3-5 fold increase in the levels of point mutations, increased 
amounts of deleted mtDNA as well as reduced lifespan, weight loss, reduced subcutaneous fat, 
hair loss, curvature of the spine, osteoporosis, anaemia, reduced fertility and heart enlargement; 
all factors seen due to aging (Trifunovic et al., 2004).  Secondly, Hance found that when the 
PolG catalytic subunit is knocked out it results in embryonic lethal and PolG deficiency in mouse 
embryos which causes early developmental arrest between embryonic days 7.5 and 8.5, 
associated with severe mtDNA depletion (Hance et al., 2005).  While both of these studies were 
in mice and knock-out primates have yet to be developed, we felt it relevant to determine if there 
were any mutations in the rhesus catalytic subunit of PolG, associated with aging, that were 
detectable in tissue from rhesus macaques at different ages.  We found no correlation between 
accumulation of mutations in the catalytic subunit of PolG and the aging phenomenon (Appendix 
2).   
We sequenced the mtDNA control region of 10 arrested GV oocytes, 20 arrested MI 
oocytes and 28 normally maturing MII oocytes from 5 rhesus macaques (Table 5).  We found no 
consistently exhibited point mutations or deletions in either GV, MI or MII oocytes, indicating 
that the failure of oocytes to complete MII of meiosis is not caused by alterations in the mtDNA 
control region (Appendix 3).  Furthermore, we found no consistently exhibited point mutation or 
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deletions in day 3 embryos that originated from normal MII oocytes, indicating that there are 
likely no changes or mutations to the mtDNA control region during fertilization and early 
embryo development. Due to the limited number of samples analyzed, we agree that these 
findings are not statistically significant and do not lead to conclusions about either the 
involvement, or lack there of, of either the mtDNA control or PolG to the aging process or 
meiotic failure.  The DNA sequencing methods available at the time of this study were limited, 
especially considering the complex, technologically advanced methods that have recently been 
developed. Furthermore, we did not sequence the entire mtDNA genome of any sample, however 
we feel the analysis of the control region, which is the location where numerous process involved 
in mtDNA replication and transcription (Table 6), may indicate that the specific sequence of the 
mtDNA control region may not be critical to the process of meiotic maturation of oocytes. 
Table 6: Sites within the mtDNA control region and base pair locations. 
Function Location 
Control Region with D-Loop 16024-576 
Hypervariable Region I 16024-16383 
Termination Sequence 16157-16172 
Control Element 16194-16208 
L-strand Control Element 16499-16506 
Hypervariable Region II 57-372 
H-strand Replication Origin 110-441 
Conserved Sequence Block I 213-235 
TFAM Binding Site 233-260 
TFAM Binding Site 276-303 
Conserved Sequence Block II 299-315 
Replication Primer 317-321 
Conserved Sequence Block III 346-363 
H-strand Control Element 371-379 
H-strand Control Element 384-391 
L-strand promoter 392-445 
TFAM Binding Site 418-445 
TFAM Binding Site 523-550 
Major H-strand Promoter 545-567 
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CHAPTER 5 
SPECIFIC AIM 4 
Introduction 
Specific Aim 4: To determine if gonadotrophin stimulation efficiency can be improved 
through optimization of gonadotrophin stimulation protocols. 
 Our laboratory has been working with the Caribbean Primate Research Center (CPRC) 
for approximately 4 years in an effort to establish a reputable rhesus macaque IVF program in 
order to pursue developmental biology grants and research projects using the CPRC as a resource 
to provide high quality rhesus oocytes, embryos and sperm.  In order to obtain rhesus macaque 
reproductive material of the highest quality, we worked onsite with the current staff at CPRC in 
order to improve the efficiency of the IVF program.  Through previous collaboration with other 
primate research centers and upon working with CPRC, it became apparent that a significant 
inefficiency of the IVF program was the gonadotrophin stimulation regimen to which the 
monkeys were subjected.  Individual NHP respond differently to gonadotrophin stimulation in 
the same manner that individual humans respond differently.  The previous gonadotrophin 
stimulation protocol that was employed at the CPRC was as follows: 37.5IU rFSH twice daily 
for 10 days with 1000IU recombinant (rhCG) given on day 10 and oocyte collection 34 hours 
later.  While this protocol worked intermittently, it generally resulted in a mediocre rate of 
mature oocytes (MII) upon collection and a high rate of GV oocytes. Therefore the objective of 
this specific aim was to identify and implement methods of gonadotrophin stimulation in order to 
improve upon the efficiency of rhesus macaque IVF at the CPRC. 
Material and Methods 
Controlled Hormonal Ovarian Stimulation 
Ovarian stimulation and oocyte recovery was adapted from previously described 
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protocols (Schramm and Bavister, 1999).  Briefly, rhesus macaque females were observed for 
signs of menstrual activity and subjected to follicular stimulation via intramuscular injections of 
(rFSH).  Prior to this study, monkeys at the CPRC received 37.5 IU of rFSH twice daily, for 10 
days.  On the final day of rFSH treatment, 34 hours before follicular aspiration, oocyte 
maturation was induced with a single injection of 1000 IU recombinant hCG. 
Oocyte Collection and Meiotic Stage Determination 
Procedures for oocyte recovery, sperm collection, insemination, and embryo culture have 
been described previously (Bavister et al., 1983a; Boatman and Bavister, 1984; Wolf et al., 
1989).  Briefly, follicular fluid was collected in TALP-HEPES containing 0.3% bovine serum 
albumin (BSA).  The aspirates were sifted through a cell strainer and oocytes were collected after 
rinsing the filter.  After cumulus removal using hyaluronidase (0.03%), oocytes were rinsed, 
meiotic stage was determined (GV, MI or MII) and placed in these groups in TALP medium 
culture drops supplemented with BSA, (Bavister and Yanagimachi, 1977), and incubated in 5% 
CO2 in air at 37°C.   
Experiment 1: Reduction of FSH dose  
Due to the high cost of rFSH used for gonadotrophin stimulation protocols, we wanted to 
determine if there was a significant reduction in the number of oocytes collected when the total 
daily dose of rFSH was reduced by half.  Animals continued to receive injections twice daily, 
however instead of 37.5IU rFSH in each injection (75IU daily), animals received 18IU rFSH in 
each injection (36IU daily). Follicular aspiration was performed as described above and numbers 
of oocytes collected was recorded.  Data from a total of 40 stimulation cycles was included in 
this comparison; 21 cycles using a high rFSH dose (75IU daily) and 19 cycles using a low rFSH 
dose (36IU daily).  Comparisons were made using a paired t-test and results were considered 
statistically significant at ? 0.05. 
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Experiment 2: Addition of rLH 
Recombinant luteinizing hormone (rLH) is commonly used in both human and NHP 
gonadotrophin stimulation protocols in an effort to mimic the acute rise and fall of LH seen in 
the natural cycle, which initiates ovulation.  In this study, monkeys were given 15IU rLH on the 
evening of day 9 of rFSH stimulation and 15IU rLH on both the morning and evening of day 10 
(30IU total on day 10).  Follicular aspiration was performed as described above and numbers of 
GV, MI and MII oocytes collected was recorded.  Data from a total of 40 stimulation cycles was 
included in this comparison: 24 cycles without LH and 16 cycles with LH.  Comparisons were 
made using a paired t-test and results were considered statistically significant at ? 0.05.  
Experiment 3: Replacement of recombinant hCG with biological hCG 
Human chorionic gonadotrophin (hCG) is widely used in both human and NHP IVF to 
induce ovulation during gonadotrophin stimulation.  Generally, a synthetically derived form of 
hCG (Ovidrel) is used instead of biologically derived forms.  Multiple NHP IVF programs have 
had great success with recombinant hCG (rhCG), however, at the CPRC, cycles using rhCG 
typically produced inconsistent numbers of mature oocytes, with a consistently large number of 
oocytes remaining at the GV phase of meiosis. As previously discussed, oocytes must reach the 
meiotic stage of MII in order for fertilization to occur, thus, GV oocytes are not capable of being 
used for IVF related studies.  Therefore, we replaced recombinant hCG with a biologically 
derived form (Pregnyl). The same dose (1000IU) and timing of injection were used in all cycles.  
Follicular aspiration was performed as described above and numbers of GV, MI and MII oocytes 
collected was recorded.  Data from a total of 40 stimulation cycles was included in this 
comparison: 24 cycles using recombinant hCG and 16 cycles using biological hCG.  
Comparisons were made using a paired t-test and results were considered statistically significant 
at ? 0.05. 
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Results 
Experiment 1: Reduction of rFSH dose: The average number of oocytes collected in the 
high rFSH group was 20.4 oocytes per collection, while the average number of oocytes collected 
in the low rFSH group was 20.8 oocytes per collection.  Figure 11 shows that the reduction of the 
previously used dosage of rFSH (75IU) to approximately half (36IU) resulted in no significant 
difference in the average number of oocytes collected per stimulation.   
 
 
 
Figure 11: Comparison of average number of oocytes collected per stimulation using either high 
FSH (75IU daily) (n=21) or low FSH (36IU daily) (n=19).  
 
Experiment 2: Addition of LH: When comparing the average percentage of MII, MI and GV 
oocytes collected per stimulation, we found no significant differences between stimulations with 
LH or without LH. While there was no significant difference found in the number of MII, MI or 
GV oocytes collected, there was an observable trend in the number of MII and GV oocytes 
collected (Figure 12) that we feel will become significant with the inclusion of data from more 
cycles.    
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Figure 12: Average percentage of MII, MI and GV oocytes collected, per stimulation, without 
LH (n=24) compared to the average percentage of MII, MI and GV oocytes collected, per 
stimulation, with LH (n=16). Standard error bars are shown. 
Experiment 3: Replacement of recombinant hCG with biological hCG:  We found that the use of 
a biological hCG resulted in a significantly higher average percentage of oocytes resuming 
meiosis and completing germinal vesicle breakdown (GVBD).  In Figure 13, we show a 
statistically significant increase in the average percentage of MII oocytes collected, as well as a 
statistically significant decrease in the average percentage of GV oocytes collected due to the 
replacement of R-hCG with B-hCG.   
 
Figure 13: Average percentage of MII, MI and GV oocytes collected, per stimulation, with 
recombinant hCG (n=24) compared to the average percentage of MII, MI and GV oocytes 
collected, per stimulation, with biological hCG (n=16). Standard error bars are shown. Statistical 
significance: a,b ? 0.05. 
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Finally, we found that the combination of the protocol changes in Experiment 2 and 3, 
i.e. the addition of rLH and the use of biological hCG, resulted in a statistically significant 
increase in the average percentage of MII oocytes collected, as well as a statistically significant 
decrease in GV oocytes collected (Figure 14).   
 
Figure 14: Average percentage of MII, MI and GV oocytes collected, per stimulation, without 
LH and using recombinant hCG (previous standard protocol) (n=22) compared to the average 
percentage of MII, MI and GV oocytes collected, per stimulation, with LH and using biological 
hCG (n=14). Standard error bars are shown. Statistical significance: a,b ? 0.05.  
Discussion 
The objective of this study was to identify and implement methods of gonadotrophin 
stimulation in order to improve upon the efficiency of rhesus macaque IVF at the CPRC.  This 
was accomplished by 1) reducing the dose of rFSH, yet maintaining the number of oocytes 
collected per stimulation, thus reducing the overall cost per stimulation cycle; 2) by significantly 
increasing the number of meiotically “normal” (MII) oocytes collected that can be used in IVF 
related studies; and 3) by significantly reducing the number of meiotically “abnormal” (GV) 
oocytes collected that are unable to be used for IVF studies. The high dose of rFSH (75IU) used 
in the previous protocol, while occasionally resulting in higher oocyte numbers (data not shown), 
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also resulted in a significantly larger number of immature oocytes, which generally cannot be 
used for IVF experiments.  While the trend in human IVF has been to collect as many oocytes as 
possible, embryologists and scientists are beginning to recognize the importance of quality 
oocytes over simply large cohorts. We have shown that reducing the rFSH dose by half has no 
significant difference on the average number of oocytes collected per stimulation (Figure 11).   
The inclusion of rLH in gonadotrophin stimulation protocols is a common practice in 
both human and NHP IVF programs.  However, until this study, it was not used at CPRC and it 
was unknown if there would be any benefit to adding it to the current protocol.  While we were 
not able to find that the addition of rLH alone significantly increased the number of MII oocytes 
collected, we did find that the combination of the inclusion of rLH, as well as replacing 
recombinant hCG with biological hCG, did result in significantly increased numbers of MII 
oocytes collected, as well significantly decreased numbers of GV oocytes collected (Figure 14).  
This is the first study to show that, not only does B-hCG increase the number of oocytes 
collected after gonadotrophin stimulation that reach meiotic maturity (MII), thus allowing more 
oocytes to be used for IVF experiments, but this is also the first study to show that monkeys can 
be subjected to more than one dose of B-hCG without becoming refractory to the drug itself.  It 
is well known that rhesus macaques can only be subjected to one stimulation cycle of biological 
FSH before becoming refractory to FSH stimulation, resulting in a complete lack of ovarian 
response and follicle development.  This is the reason why most protocols use a recombinant 
form of FSH, as we have used throughout this study, in order to stimulate each animal multiple 
times.  The practice of using an animal for multiple stimulation protocols is well established and 
reduces the number of animals needed for experimentation.  Concomitantly, it has been assumed 
that a typical refractoriness would be seen with biological hCG as has been historically seen with 
biological FSH.  However, we have found that animals can be given biological hCG up to three 
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times with no detrimental effect to the process of ovulation (data not shown).  Furthermore, we 
have shown here that biological hCG significantly increases the number of meiotically “normal” 
oocytes (MII) collected as well as reducing the number of unusable oocytes (GV).  The changes 
to standard IVF protocols we have used in this study will enable the collection of higher quality 
reproductive material to be used for future research projects as well as reducing unusable 
material and the overall cost of reproductive research in the rhesus macaque.  
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CHAPTER 6 
SPECIFIC AIM 5 
Introduction 
Specific Aim 5.1: To determine if expression levels of genes controlling mitochondrial 
dynamics are correlated to the failure of oocytes to resume meiosis.  
Specific Aim 5.2: To determine if expression levels of genes controlling mitochondrial 
dynamics are correlated to important preimplantation development time points. 
Interest in the mitochondrion and its role in the preimplantation mammalian embryo has 
had a recent resurgence (Bavister and Squirrell, 2000; Van Blerkom, 2000).  Prior studies have 
shown that mitochondria are initially morphologically immature; spherically shaped rather than 
elongated, with relatively few cristae; and undergo a maturation process prior to blastocoel 
formation.  The general process of mitochondrial maturation has been described for multiple 
species; mouse (Hillman and Tasca, 1969); pig (Hyttel and Niemann, 1990); bovine (Plante and 
King, 1994) and primates (Panigel et al., 1975).  It is also understood that mitochondria undergo 
a variety of species-specific reorganizations during early preimplantation development.  
Mitochondria in hamster embryos reorganize from a homogeneous distribution in the oocyte to a 
distinct perinuclear organization late in the pronucleate and two-cell stages (Barnett et al., 1996).  
Mitochondrial distribution has also been associated with developmental competence in multiple 
species including hamster (Barnett et al., 1997; Lane and Bavister, 1998; Squirrell et al., 2001); 
mouse (Muggleton-Harris and Brown, 1988); pig (Hyttel and Niemann, 1990) and cattle (Van 
Blerkom et al., 1990).  It has been shown that in oocytes and early cleavage stage embryos in 
multiple species, including hamster and mouse (Van Blerkom, 1991), that mitochondria have a 
distinct pronuclear translocation and that perturbations from these patterns result in embryonic 
lethality.  Human zygotes have shown a pronuclear accumulation of mitochondria (Noto et al., 
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1993; Van Blerkom et al., 2000), as well as significantly different mitochondrial localization 
patterns between individual oocytes between and among cohorts.  Furthermore, pronuclear 
oocytes that showed a pronounced asymmetrical mitochondrial distribution during syngamy 
continued to show an asymmetrical distribution after the first cell division, and between 
blastomeres throughout embryo development.  When analyzed individually, the blastomeres 
containing less mitochondria also had lower ATP content compared to blastomeres with higher 
mitochondrial content (Van Blerkom et al., 2000).  Additional studies in the rhesus have shown 
that zygotes exhibit a distinct organization of mitochondria that accumulate between the male 
and female pronuclei, similar to the human (Squirrell et al., 2003).  There is also marked 
difference is the heterogeneity of mitochondrial organization among oocytes, which may reflect 
the heterogeneity of oocyte quality and developmental competence in primates, unlike 
homogeneity in hamsters (Barnett et al., 1996).  It is possible that the localization of 
mitochondria in rhesus zygotes is a result of mitochondria undergoing fusion and fission 
processes during preimplantation resulting in what appears to be the microtubule network 
guiding the mitochondria to their pronuclear location.  It has also been shown that the pronuclear 
accumulation of mitochondria in rhesus oocytes is transient, on the order of a few hours, 
although the exact length of time remains uncertain (Squirrell et al., 2003).  
It is well established that during the early stages of development, embryo competence 
depends upon ATP produced by mitochondria inherited from the mother.  During the early 
stages of embryo development, energy is produced by OXPHOS via amino acids, lactate and 
pyruvate, with the glucose pathway proving to be harmful at this stage; indicating that a 
threshold of mitochondrial activity is necessary to support energetic demands (Tarazona et al., 
2006).  Once embryonic genome activation begins, the metabolic activity of the embryo 
increases as it becomes capable of using alternative pathways such as anaerobic glycolysis, 
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allowing mitochondrial activity to decrease.  While the lack of mitochondrial organization has 
been correlated to poor embryo development and poor implantation in the human (Scott and 
Smith, 1998), the exact influence of mitochondrial distribution on embryo competence remains 
to be determined.   
The molecular analysis of mitochondrial dynamics began in 1997 with the identification 
of the Drosophila mitofusin gene Fzo (Hales and Fuller, 1997).  Fzo is a mitochondrial outer 
membrane GTPase required for mitochondrial fusion during spermatogenesis.  The core genes 
mediating mammalian mitochondrial fusion are Mfn1, Mfn2 and Opa1.  Mfn1 and Mfn2, the 
mammalian homologues to Fzo, are large GTPases with similar homology and topologies that 
reside on the outer mitochondrial membrane (Chen and Chan, 2004).  Opa1 is an inter membrane 
space protein and is also essential for fusion (Detmer and Chan, 2007).  The exact relationship 
between these proteins remains unclear, however cells lacking any of the three proteins have 
been shown to have inhibited respiratory capacity.  Additionally, the contact between the inner 
and outer membranes, where these proteins reside, is essential to mitochondrial fusion (Detmer 
and Chan, 2007).  The core genes mediating mitochondrial fission are Drp1, Fis1 and MTP18.  
Drp1 is a large dynamin related GTPase located primarily in the cell cytosol.  A portion of Drp1 
moves to the mitochondrial tubule where it interacts with Fis1 (Parone and Martinou, 2006), 
which is a transmembrane protein anchored to the mitochondrial outer membrane.  Both Drp1 
and Fis1 have been implicated in mitochondrial outer membrane permeability and mediate 
downstream apoptosis (Chen and Chan, 2004).  Inhibition of Drp1 has been shown to delay 
mitochondrial division and partially inhibit apoptosis.  MTP18 is a mitochondrial protein that 
contributes to the balance of mitochondrial fission and fusion.  Changes in the expression levels 
of MTP18 interfere with the balance of mitochondrial fission and fusion; whereas loss results in 
increased mitochondrial fusion and an increase results in increased number of fragmented 
73 
 
 
mitochondria (Tondera et al., 2005).  As previously stated, mitochondria move along both 
microtubules and actin, using microtubule-based molecular motors for long distance movements 
(Morris and Hollenbeck, 1995).  Distribution of mitochondria varies in response to multiple 
regulatory cues such as energy requirements, growth factors and mitochondrial membrane 
potential (Chada and Hollenbeck, 2004; Miller and Sheetz, 2004; Morris and Hollenbeck, 1993).  
Mutations in either of two of the components identified to be important for transport; Milton 
(Stowers et al., 2002) and Miro (Guo et al., 2005) appears to abolish anterograde mitochondrial 
transport.  It has been shown (Glater et al., 2006) that kinesin, Milton, and Miro work together in 
anterograde transport and that Milton attaches kinesin to mitochondria through Miro.  Pink1, a 
putative serine–threonine kinase that localizes to the outer mitochondrial membrane, has been 
shown to have a role in cellular protection against oxidative stress and to affect mitochondrial 
dynamics.  Recent ndings have shown that Pink1 interacts with the Miro/Milton complex and 
that overexpression of either Miro or Milton can suppress mitochondrial fragmentation induced 
after Pink1 silencing (Weihofen et al., 2009).  Pink1 and Parkin, a gene associated with 
Parkinson’s disease, are linked in a common pathway that is involved in the protection of 
mitochondrial integrity and function (Pridgeon et al., 2007).  Our lab has recently found that 
monkey oocytes have an abundance of Miro1 and 2, Milton, Pink1, Parkin, Mfn1, Mfn2 and 
Drp1 (unpublished data).  Therefore we speculate that mitochondrial trafficking is important for 
fusion and fission mechanisms and may impact oocyte and embryo quality. 
Materials and Methods   
Ovarian Stimulation, Oocyte Recovery and In Vitro Fertilization 
All supplies were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise 
indicated.  Ovarian stimulation and oocyte recovery was adapted from previously described 
protocols by Schramm et al (Schramm and Bavister, 1999).  Briefly, rhesus macaque females 
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were observed for signs of menstrual activity and subjected to follicular stimulation via 
intramuscular injections of (rFSH) as follows; Days 1-10 rFSH twice daily; day 9 (P.M.), (rLH) 
once and day 10 rLH twice (A.M. and P.M.).  On the night of the 10th day, the animal was 
injected with bhCG.  The employment of rLH in this manner was to mimic the endogenous surge 
of LH followed by hCG. Procedures for oocyte recovery, sperm collection, insemination, and 
embryo culture have also been described previously (Bavister et al., 1983a; Boatman and 
Bavister, 1984; Wolf et al., 1989).  Briefly, follicular fluid was collected in TALP-HEPES 
containing 0.3% bovine serum albumin (BSA).  The aspirates were sifted through a cell strainer 
and oocytes were collected after rinsing the filter.  After cumulus removal using hyaluronidase 
(0.03%), oocytes were rinsed, meiotic stage was determined (GV, MI or MII) and oocytes were 
placed in these groups in modified CMRL medium and incubated in 6% CO2 in air at 37°C.  
Rhesus semen was collected by penile electroejaculation (Lanzendorf et al., 1990).  Sperm count 
and motility analyses were performed, spermatozoa cleaned with TL-HEPES medium, 
resuspended and stored in TALP and allowed to equilibrate in the incubator at 6% CO2 at 37°C 
for at least two hours.  Just before insemination, MI oocytes were examined for maturation and 
oocytes were inseminated in three groups; MII, MI and MI matured to MII (MI-MII) before 
insemination.  This second assessment of oocyte maturation established a group of oocytes that 
matured from MI to MII between the time of collection (33-34 hrs post hCG) and the time of 
insemination (37-38 hours post hCG).  Previous work in our laboratory (Dupont et al., 2009) has 
shown that this period of time is important in chromosomal aneuploidy and mosaicism.  All 
oocytes were placed into equilibrated, modified TL within the three groups. Spermatozoa were 
activated with dbcAMP and caffeine (1mM each) and used for insemination of all MII, MI and 
MI-MII oocytes at a final concentration of 1.5–2.0×105 sperm/mL.  Approximately 12-14 hours 
later, presumptive zygotes were cleaned of sperm and placed into fresh TL for fluorescent 
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imaging.  To guarantee the removal of all granulosa cells and sperm, oocytes were aspirated with 
plastic stripper tips (Mid Atlantic Diagnostics, Marlton, NJ, USA).  
For oxygen concentration studies, all oocytes were inseminated under high O2 levels (6% 
CO2/20% O2).  Fourteen hours after insemination, presumptive zygotes were randomly placed in 
amino acid-supplemented HECM-6 culture drops (Schramm and Bavister, 1996) and incubated 
under either high O2 (6% CO2/20% O2) or low O2 (6% CO2 /5% O2 /89% N2) at 37°C until day 3.  
All embryos used for the oxygen concentration study originated from MII oocytes at the time of 
collection in order to eliminate the possibility of maturation stage differences.  
Imaging 
For zygotes: 13 hours post-insemination, zygotes exhibiting 2 pronuclei (2PN) were 
placed into MitoTracker Orange CMTMRos (Molecular Probes), which passively diffuses across 
the plasma membrane and accumulates in active mitochondria, as well as a nucleic acid stain, 
Hoechst 33342.  After incubation for 45 minutes, zygotes were rinsed through 3 drops of fresh 
modified TL to remove excess stain, and immunofluorescence detection of mitochondrial 
localization and nuclei was assessed using fluorescence microscopy. 
For embryos: approximately 72 hours post-insemination, digital images of each embryo 
was taken for assessment of quality grade.   
Fluorescent and brightfield imaging was performed as quickly as possible in order to 
prevent damage caused by exposure to light.  
RNA Analysis and cDNA Synthesis 
Immediately after either fluorescent or brightfield imaging, zygotes and embryos were 
individually placed into cell lysis buffer according to the published protocol from the Stratagene 
Absolutely RNA Nanoprep Kit (Stratagene, La Jolla, CA, USA), snap frozen in LN2 and stored 
at -80oC to preserve RNA for later analysis.  Following thawing on ice and according to the 
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manufacturer’s instructions, RNA from the zygotes and embryos was extracted using the 
Absolutely RNA Nanoprep Kit (Stratagene, La Jolla, CA, USA). Recovered RNA was reverse 
transcribed into cDNA using random hexamers and Superscript III reverse transcriptase 
(Invitrogen, San Diego, CA, USA) following instructions from the manufacturer.   
Multiplex target specific preamplification of cDNA 
Custom TaqMan gene expression assays for genes encoding mitochondrial fusion 
(Mfn2), fission (Drp1), mitochondrial transport (Miro1 and Pink1) and mitochondrial replication 
(SSBP1) that were previously designed in our laboratory were employed in this study.  In 
addition to these custom-made gene expression assays, a commercially available primer pair and 
probe for eukaryotic 18S rRNA was purchased (Applied Biosystems, Foster City, CA, USA).  
A multiplex PCR preamplification of 5 cDNA targets was performed in a final volume of 
25?l using a commercial PreAmplification Mix (Applied Biosystems, Foster City, CA, USA) 
according to manufacturer’s instructions. Because of its high abundance, the endogenous control 
18S rRNA was not preamplified.  Reaction mixtures were initially held at 95°C during 10 min 
before 14 preamplification cycles of 15 sec at 95°C and 4 min at 60°C were executed.  The 
linearity of the preamplification was tested following quantitative real-time PCR of both 
unamplified and diluted (1:20) preamplified 0.1 ng/?l rhesus macaque testis cDNA.  Within the 
unamplified and preamplified testes cDNA group, CT values from all the transcripts of interest 
were compared to a randomly chosen reference gene out of the 5 genes of interest.  The ?CT 
values for each gene were subtracted from each other and resulting values (??CT) were 
indicative of the linearity of the preamplification.  The ??CT values approximating zero were 
considered linear, whereas values exceeding two were regarded as undesirable.  To guarantee the 
linearity of the reference gene, the complete calculation was repeated using another reference 
gene out of the 5 preamplified targets. 
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Quantitative Real-Time PCR 
Triplicate amplifications were conducted in a 10?l final reaction volume using the 
7900HT Fast Real-Time PCR System.  The reaction mixture contained 1x TaqMan Universal 
Master Mix (Applied Biosystems, Foster City, CA, USA), 1x TaqMan Gene Expression Assay 
(Applied Biosystems, Foster City, CA, USA) and 2.5 ?l of preamplified cDNA.  After an initial 
hold at 95°C for 10 min, reaction mixtures underwent 40 cycles of 15 sec at 95°C and 1 min at 
60°C.  In order to create the standard curves, ten-fold dilutions of diluted (1:1) 0.1 ng/?l 
preamplified rhesus macaque testis cDNA were quantified on the same plate as diluted (1:20) 
preamplified zygote cDNA.  Following the amplification, the threshold and baseline values for 
each gene were empirically determined and remained constant over all plates.  The threshold 
values from each transcript of interest were used to approximate RNA equivalents from the 
standard curve.  Following this extrapolation, each RNA equivalent was normalized to the non-
preamplified 18S RNA equivalent.   
Results 
Zygote Data Analysis 
Zygotes originating from the three maturation groups (MI, MII, MI-MII) from eight 
rhesus macaque females were analyzed in this study.  Details of monkey oocytes from the three 
maturation groups are summarized in Table 7.   
Our initial goal was to correlate mitochondrial movement throughout the embryo during 
syngamy with expression of genes known to control mitochondrial dynamics and movement.  
While we were able to collect images of mitochondrial localization at the zygote stage that show 
the heterogeneity of mitochondrial distribution in a population of NHP zygotes (Figure 15) 
regardless of maturation status of the original oocyte (MI, MII or MI-MII), we were not able to 
correlate these images with gene expression profiles. 
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Table 7: Animal identification and numbers of zygotes used from each animal.  
Animal ID MI MII MI-MII 
98H 3 - - 
53O 2 - - 
15S - 3 5 
12S 4 - - 
80C 1 5 1 
76P - 5 - 
M598 2 - 5 
88J - 5 1 
Total 12 18 12 
 
 
Figure 15:  Mitotracker staining of 4 rhesus macaque zygotes, from 4 different animals, 14 hours 
post insemination.  Note the heterogeneity between the individual zygotes 
Previous studies by Squirrell (Squirrell et al., 2003) employed the use of confocal 
microscopy and multi-photon laser scanning microscopy (MPLSM).  Neither of these 
technologies were available at the CPRC and therefore all images were taken using 
epifluorescense, which does not allow pinpoint images of the cell to be taken.  Because of the 
limitations of epifluorescense and the available microscope, we cannot definitively say that 
mitochondrial localization, i.e. perinuclear localization during syngamy, is correlated to the 
expression of genes controlling mitochondrial dynamics and movement.  However, mitochondria 
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are most certainly going through fusion, fission and movement processes during fertilization and 
syngamy as can be seen by the differences in mitochondrial morphology and localization in the 
images.  Further studies need to be performed using confocal or MPLS microscopy.   
Due to the success of the gonadotrophin stimulation protocol (Chapter 5) and the high 
percentage of MII oocytes upon collection, it was not possible to use equivalent numbers of 
oocytes from each female for each maturation group.  Therefore no comparisons were made 
between animals and each zygote was treated individually within the three maturation groups; 
MI (n=12), MII (n=18) and MI-MII (n=12) (Table 7).  Using the Student-Neuman-Keuls Test, 
that compares the means of all three maturation groups to each other, for each individiual gene of 
interest, we found no significant differences in the relative expression levels of all 5 genes 
between the three maturation groups (Table 8). 
Table 8. Means and number of samples analyzed (N) for each maturation group for each gene of 
interest 
Maturation 
Group N Mfn2 Pink1 Drp1 Miro1 SSBP1 
MII 12 81.60 27.86 103.48 175.12 153.33 
MI  12 72.54 15.17 62.16 90.05 103.58 
MI-MII 18 34.53 11.34 35.26 43.63 52.67 
Significance  0.414 0.356 0.295 0.234 0.196 
Student-Neuman-Keuls Test was used to compare the means of the 3 maturation groups to each other, 
for all 5 genes of interest. No significant differences found. 
Expression analyses revealed all genes analyzed were highly correlated; indicating that 
mitochondrial fusion (Mfn2), fission (Drp1), movement (Pink1, Miro1) and replication (SSBP1) 
are all strongly (p<.001) associated with each other during syngamy and preimplantation 
development (Table 9). 
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Table 9: Pearson correlation analysis showing strong correlation between all 5 genes of interest 
for all zygotes analyzed, regardless of maturation group. 
 Pink1 SSBP1 Mfn2 Drp1 Miro1 
Pearson Correlation 1 .873** .827** .933** .980** 
Sig. (2-tailed)  .000 .000 .000 .000 
Pink1 
N 41 41 41 41 41 
Pearson Correlation .873** 1 .939** .893** .871** 
Sig. (2-tailed) .000  .000 .000 .000 
SSBP1 
N 41 42 42 42 42 
Pearson Correlation .827** .939** 1 .884** .789** 
Sig. (2-tailed) .000 .000  .000 .000 
Mfn2 
N 41 42 42 42 42 
Pearson Correlation .933** .893** .884** 1 .909** 
Sig. (2-tailed) .000 .000 .000  .000 
Drp1 
N 41 42 42 42 42 
Pearson Correlation .980** .871** .789** .909** 1 
Sig. (2-tailed) .000 .000 .000 .000  
Miro1 
N 41 42 42 42 42 
**. Correlation is significant at the 0.001 level (2-tailed). 
Pearson Correlations with Sig.(2-tailed) indicating all p?0.001 and N = total number of 
samples analyzed regardless of maturation group. 
Embryo Data Analysis 
Embryos from 3 rhesus macaque females were used for this study.  Fourteen hours after 
insemination, embryos were places in either low O2 (n=12) or high O2 (n=12).  Real-Time PCR 
gene expression analysis of the same 5 genes analyzed in zygotes revealed no significant 
difference between day 3 embryos cultured under low O2 versus high O2 (Figure 16 & Table 10). 
 
Figure 16: Comparison of relative expression levels of genes involved in mitochondrial 
dynamics and replication in day 3 embryos cultured under either low or high oxygen 
concentration.  Each gene is normalized to the internal control, ribosomal 18S.  No significant 
differences shown. 
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Table 10: Genes involved in mitochondrial dynamics and replication in day 3 embryos cultured 
under either low or high oxygen concentration. 
 Oxygen Concentration N Mean Std. Deviation Std. Error 
Low 11 1.09214 0.466822 0.140752 Pink1 
High 10 1.25179 0.393131 0.124319 
Low 11 10.05574 3.627983 1.093878 SSBP1 
High 11 9.06683 7.760284 2.339814 
Low 11 6.79198 4.248865 1.281081 Mfn2 
High 11 6.92026 2.357120 0.710698 
Low 11 5.37615 2.296540 0.692433 Drp1 
High 11 5.93824 2.239771 0.675316 
Low 10 3.77506 2.374944 0.751023 Miro1 
High 11 5.30295 2.076477 0.626081 
Showing mean, samples analyzed (N), standard deviation and standard error of relative expression 
levels of genes involved in mitochondrial dynamics and replication in day 3 embryos cultured 
under either low or high oxygen concentration. Each gene is normalized to the internal control, 
ribosomal 18S. 
 
Preimplantation Development Analysis 
Mature MII oocytes that were previously analyzed in our lab for the same 5 genes of 
interest were included in this analysis.  The inclusion of this data allowed comparison of three 
distinct time points during preimplantation development; oocyte, zygote and day 3 embryo.  All 
material used for this analysis originated from mature MII oocytes at the time of collection in 
order to eliminate the possibility of maturation stage differences.  The data for all three groups of 
interest were non-normally distributed and therefore a Krustal-Wallis one-way ANOVA by ranks 
was used.  Krustal-Wallis is a non-parametric method for testing the equality of population 
medians among groups.  It is identical to a one-way ANOVA with the data replaced by their 
ranks.  As shown, MII oocyte gene expression is at basal levels for all genes analyzed except for 
Pink1 (Table 11).  After fertilization and during syngamy (zygote stage) all genes increase 2-3 
fold from levels seen in the oocyte (Table 11).  By day 3 of embryo development, all genes have 
decreased to levels still significantly higher than those seen in the oocyte (except for Mfn2 and 
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Pink1), but also significantly lower than what is seen in the zygote.  Table 11 and Figure 17 
show the mean rank comparisons of each gene for the 3 developmental groups.  All comparisons 
are statistically significant (p<0.001) except for Mfn2 expression in oocytes vs. embryos. 
Table 11: Mean rank using the Krustal-Wallis Test for each of the three maturation groups for 
each gene. 
 Oocyte Zygote D3 Embryo Oocyte vs Zygote 
Oocyte vs D3 
Embryo 
Zygote vs D3 
Embryo 
Mfn2 14.93 46.72 22.33 < 0.001 0.172 < 0.001 
Drp1 10.87 46.67 25.92 < 0.001 0.002 < 0.001 
Pink1 28.07 44.67 14.58 < 0.001 0.004 < 0.001 
Miro1 12.8 45.67 21.18 < 0.001 0.186 < 0.001 
SSBP1 8.4 46.39 30.67 < 0.001 < 0.001 < 0.001 
N 15 18 12    
Each sample analyzed, regardless of developmental time point (N=45) is ranked, using the relative 
expression normalized to ribosomal 18S, from highest to lowest, and the mean of each time point is 
compared to the mean of every other time point, for each individual gene. Each comparison is statistically 
different for each comparison except for Mfn2 and Miro 1 in oocyte vs day 3 embryo. 
 
 
Figure 17: Data depicting the Krustal-Wallis test using mean rank.    
Finally, a small subpopulation of zygotes and embryos were found to have dramatically 
higher levels of gene expression of all 5 genes of interest.  As shown in Figure 18, scatterplots 
reveal this is especially true in zygotes.  Raw data from this subpopulation is shown in Table 12. 
Expression of all five genes is highly correlated as shown in Table 9.   
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Figure 18: Scatterplots of MII oocytes, zygotes and day 3 embryos that express dramatically 
higher expression levels. 
Table 12: Relative expression levels 
Animal ID Pink1 SSBP1 Mfn2 Drp1 Miro1 
80C 8.417 25.048 25.944 11.157 31.397 
80C 77.336 414.239 260.978 372.071 473.345 
76P 5.908 89.272 39.87 42.226 80.255 
76P 19.728 352.451 97.429 44.904 127.845 
88J 10.218 37.299 32.213 23.881 32.37 
88J 37.8 383.488 174.988 103.61 371.384 
15S 10.963 48.645 41.01 29.486 29.973 
15S 167.599 561.784 274.333 493.693 1,183.635 
15S 77.312 454.633 277.142 465.973 477.528 
73J 1.546 6.428 3.494 7.101 3.514 
73J 17.592 482.643 111.949 220.513 385.024 
Shown are samples with typical expression levels (white) and matched samples from the 
same animal that fall within the subpopulation of samples with dramatically higher 
expression levels (green). 
Discussion 
The suppositions of this aim were primarily based on previous work that showed the 
accumulation of mitochondria between the male and female pronucleus in rhesus macaque 
zygotes and the heterogeneity of mitochondrial localization in rhesus oocytes, zygotes and 
embryos (Squirrell et al., 2003).  While that study did confirm the transient nature of 
mitochondrial localization during NHP preimplantation development, it did not examine what 
factors may be contributing to these mitochondrial movements.  In the present study, we have 
been successful in correlating expression of genes involved in mitochondrial dynamics and 
movement, as well as mtDNA replication, with specific time points in preimplantation 
development that have been previously shown to be important in mitochondrial activity.   
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The hypothesis of this specific aim were twofold.  Our initial hypothesis was that meiotic 
stage and mitochondrial distribution after fertilization influence expression of genes involved in 
mitochondrial dynamics.  As previously discussed, in order for proper fertilization to occur, the 
GV-stage oocyte, which is arrested at the diplotene stage of MI, must resume meiosis and reach 
MII, with the extrusion of the first polar body.  The use of standard ART protocols in human 
infertility treatment can result in the failure of meiotic resumption in 15 – 27% of oocytes within 
the standard 36 h after the administration of hCG (de Vos et al., 1999; Junca et al., 1995).  
Immature oocytes (GV or MI) are generally collected at oocyte retrieval along with mature MII 
oocytes.  Typically, oocytes are collected 32-34 hours post hCG injection and cultured for 
approximately 4 hours, after which, some MI oocytes will extrude a polar body, achieve MII and 
subsequently be used for IVF.  It is fairly common for immature MI oocytes from human IVF 
cycles to fertilize and develop into morphologically normal embryos (de Vos et al., 1999; Huang 
et al., 1999; Junca et al., 1995; Strassburger et al., 2004), however these embryos generally lead 
to reduced pregnancy and live birth rates (de Vos et al., 1999; Vanhoutte et al., 2005).  
Furthermore, previous studies have shown that embryos developed from oocytes with delayed 
polar body extrusion display high rates of chromosomal abnormalities regardless of morphology 
(Dupont et al., 2009).  In this study, we determined expression levels of genes involved in 
mitochondrial fusion (Mfn2), fission (Drp1), movement and transport (Pink1, Miro1) and 
replication (SSBP1) in zygotes originating from mature MII oocytes, immature MI oocytes and 
oocytes that matured during the window of time between collection and insemination (MI-MII) 
(Table 7).  We found no differences in gene expression levels in any of the five genes analyzed 
between the three maturation groups (Table 8).  It is assumed that oocytes that had not extruded 
the first PB by the time of insemination (MI group) must have extruded it sometime while in the 
presence of sperm, in order for fertilization and PN formation to have occurred.  With these data, 
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we propose that oocyte maturation to MII, from the span of time between collection (33-34 hrs 
post hCG) and insemination (37-38 hrs post hCG), while involved in chromosomal normality 
and stability (Dupont et al., 2009), does not influence the mitochondrial contribution to the 
processes of fertilization and syngamy.  Interestingly, we did find very strong correlations 
between all genes analyzed.  Indicating, for the first time, that mitochondrial fusion (Mfn2), 
fission (Drp1), movement (Pink1, Miro1) and transcription (SSBP1) are all strongly (p<0.001) 
associated with each other during syngamy and preimplantation development (Table 9). 
Our secondary hypothesis in this specific aim was that oxygen concentration during 
embryo culture influences expression of genes involved in mitochondrial dynamics.  Cohorts of 
zygotes from 3 different animals that all originated from MII oocytes upon collection were 
randomly assigned to embryo culture in either high O2 (6% CO2 / 20% O2) or low O2 (6% CO2 / 
5% O2 / 89% N2) until day 3.  The same five genes that were analyzed in zygotes above were 
analyzed in day 3 embryos in order to determine if differences in gene expression were 
influenced by oxygen concentration during in vitro embryo culture.  We found no significant 
differences in gene expression for any of the five genes of interest between low and high O2 
concentration (Figure 16 and Table 10).  Due to the low number of embryos analyzed (Table 10) 
in each group, we agree these data are not conclusive.  However, we propose that the paucity of 
differences between the low and high oxygen culture conditions may be due to the fact that all of 
these embryos were inseminated under high O2, and only split into different O2 treatments 14-16 
hours post insemination.  We propose future studies in which cohorts of oocytes are randomly 
split into low or high O2 groups, inseminated and cultured to blastocyst stage of development and 
then analyzed for the same genes analyzed here.  We predict that non-physiological O2 
concentrations (20% O2) will negatively impact mitochondrial dynamics gene expression in 
blastocysts. The blastocyst stage of development is the first formation of two distinct cell lines, 
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the ICM and the trophectoderm, as well as the time of mitochondrial replication and transcription 
in most species.  Clearly, this is an extremely important stage of development.  The impact of 
mitochondria at this stage has been well established; however, the exact role played by 
mitochondrial dynamics and movement has yet to be determined. 
Additionally, with the inclusion of similar gene expression data collected in our 
laboratory from MII oocytes, we have been able compile gene expression levels from three 
distinct time point in preimplantation development.  For the first time, we are able to show that 
expression of genes involved in the control of mitochondrial fusion, fission, movement and 
replication fluctuates during preimplantation development in NHP, depending upon the stage of 
development.  In the MII oocyte, gene expression is at basal levels for all genes analyzed except 
for Pink1 (Table 11), while in the zygote, all genes increase 2-3 fold from levels seen in the 
oocyte (Table 11).  By day 3 of embryo development, Drp1, Miro1 and SSBP1 levels have 
decreased, but remain significantly higher than those seen in the oocyte, but also significantly 
lower than what is seen in the zygote.  There were no significant differences observed for Mfn2 
between the oocyte and embryo time points.  Interestingly, Pink1, a serine–threonine kinase that 
localizes to the outer mitochondrial membrane that has a role in cellular protection against 
oxidative stress, was actually statistically higher in the oocyte than in the day 3 embryo.  The 
reason for this expression level in the oocyte is unknown.  These data show that throughout 
preimplantation development, certain time points are metabolically quiet (oocyte and day 3 
embryo), while other time points require dramatic increases in metabolism (zygote).  It is likely 
that increased ATP is needed in order to meet the energetic demands of the embryo for the 
processes occurring during these developmental stages (i.e. PN formation, polar body extrusion, 
syngamy and perhaps even mitochondrial replication, as discussed in Specific Aim 1).  Future 
studies that will determine gene expression in the blastocyst will be of great importance in 
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establishing a true profile of mitochondrial metabolic activity during preimplantation 
development.  
Interestingly, in both zygotes and day 3 embryos, there emerged a subset of samples with 
dramatically higher expression of all genes (Figure 18).  As shown in Table 12, expression levels 
of these samples can exceed two and even three standard deviations beyond the mean of the total 
cohort.  The subpopulation is not revealed in the oocyte, however, these samples were not from 
the same group of animals used for the zygote and embryo studies and the quality of the oocytes 
analyzed is questionable.  Through the use of exogenous gonadotrophin stimulation, oocytes that 
would have normally become atretic in monovulatory species such as humans and NHPs actually 
become dominant follicles due to the excess FSH available.  While these oocytes may reach MII 
status and ovulate, the quality of these oocytes is suspect.  As discussed in Chapter 1, there is not 
a benchmark method of identifying poor or good quality oocytes based on anything besides 
morphology assessment by the embryologist and the achievement of MII. Furthermore, poor or 
bad embryos can be identified based upon morphology and embryonic arrest during the cleavage 
stages; however, it remains difficult to identify a high quality embryo based upon anything 
beyond development rate and morphological quality score.  We propose the subpopulation of 
zygotes and embryos seen in Figure 18 and Table 12 were derived from oocytes that were of the 
highest quality and naturally selected for ovulation.  The dramatically higher levels of gene 
expression is not seen in all samples because cohorts are largely comprised of lower quality 
oocytes, zygotes and embryos.  This hypothesis is supported by human IVF data from 2007 that 
revealed only 39.6% of cycles performed resulted in a live birth with an average of 2.2 embryos 
used per transfer (2007 SART National Summary).  While the number of embryos produced was 
not revealed in the SART data report, there were most certainly a significantly larger number of 
embryos produced that arrested at some point during development, indicating that a 
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subpopulation of embryos were likely of much higher quality than the majority of the cohort.  
Furthermore, as previously discussed, a high proportion of genetically abnormal mitochondria in 
the oocyte can potentially reduce the number of functional mitochondria, leading to embryonic 
arrest and failed implantation.  We believe this hypothesis to be true as seen by the low 
expression of genes involved in mitochondrial dynamics, movement and replication in the 
majority of the samples analyzed.  Further analysis of a larger sample size for all time points, as 
well as other critical time points in preimplantation development (blastocyst), will likely reveal 
even further the impact of mitochondria on preimplantation development. 
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CHAPTER 7 
CONCLUSION 
The central goals of this study were to evaluate mitochondria in NHP oocytes and 
embryos, to determine how mtDNA mutations and mitochondrial function affect oocyte and 
embryo quality and to establish the rhesus macaque as an excellent comparative model to study 
preimplantation development in the human.  The major topics addressed in this dissertation were: 
• determine if there is a large mitochondrial mutation present in the rhesus macaque similar 
to the common deletion (mtDNA4977) seen in humans 
• determine if mature oocytes and IVF produced embryos from gonadotrophin stimulated 
rhesus macaques harbor a higher proportion of specific mtDNA mutations than immature 
oocytes from non-stimulated monkeys 
• determine if the rhesus common mutation is present in in vitro and in in vivo derived 
embryonic stem cell lines, as well as adult stem cell lines 
• determine if polymorphisms in the mtDNA control region as well as polymorphisms in 
the mtDNA repair mechanism, PolG, are associated with aging 
• determine if failure of oocytes to reach maturity is due to specific polymorphisms in the 
mtDNA control region 
• determine if mtDNA control region sequence differences exist between embryos 
• determine how to improve gonadotrophin stimulation methods and IVF efficiency at the 
Caribbean Primate Research Center 
• determine if, during syngamy, expression of genes involved in mitochondrial dynamics, 
transport and replication are influenced by meiotic stage of gonadotrophin stimulated 
oocytes at the time of collection 
• determine if expression of genes involved in mitochondrial dynamics, transport and 
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replication are influenced by mitochondrial distribution during syngamy 
• determine expression profiles of genes involved in mitochondrial dynamics, transport and 
replication during syngamy and early embryo development 
 We determined that the rhesus common deletion entails the loss of 5703 base pairs, 
which is considerably larger than the 4977 bp common deletion typically found in humans.  
Using the same experimental strategy we found that the rate of detection of the rhesus common 
mutation in immature GV oocytes was dramatically lower when compared with gonadotrophin-
stimulated MII oocytes and embryos (Chapter 2).  It has been suggested that there is a massive 
amplification of the mitochondrial genome during the process of oogenesis, presumably to 
support the initial period of embryonic development, and that mitochondrial replication occurs 
during a very short period of time from the 1-to 2-cell stage in the mouse embryo prior to 
fertilization (McConnell and Petrie, 2004).  Our data, as well as others’, indicates that a 
mitochondrial replication event may occur during either exogenous gonadotrophin stimulation, 
and/or during oocyte maturation (Chapter 2).  
Once we had established that there is, in fact, a rhesus common deletion and that this 
deletion is present in both mature oocytes and IVF embryos, we felt it important to determine if 
this mutation potentially persists into ESC lines derived from IVF produced embryos.  This was 
the first study to examine mtDNA mutations in embryonic and adult NHP stem cell lines and we 
determined that the rhesus common deletion is present in adult and ES cells from fertile rhesus 
macaques.  In conjunction with Chapter 2 we have shown that oocytes and embryos from 
gonadotrophin stimulated monkeys contain mitochondrial deletions, which carry into ES cell 
derivatives.  Furthermore, we have shown that adult stem cell lines harbor high levels of the 
rhesus mtDNA common deletion, regardless of passage, as well as ESC derived from both in 
vivo and in vitro produced rhesus embryo (Chapter 3).  
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We agree that further studies that both characterize other mutations that may have 
occurred in conjunction with the rhesus common mutation in oocytes and embryos, as well 
exploring the mechanisms behind the transfer of mutations from the embryo to ESC, should have 
been performed.  However, immediately following the data collection and analysis used in the 
two publications that became Specific Aim 1 and 2, Hurricane Katrina ravaged New Orleans, as 
well as the University of New Orleans, and all material collected for further analyses was 
destroyed.  It eventually became imperative for our laboratory to relocate to Wayne State 
University.  During that time, the field of determining mitochondrial impact on primate 
development changed dramatically and we were no longer in collaboration with Tulane Primate 
Research Center, the provider of all the material used in Specific Aim 1 and 2.  Upon becoming 
reestablished at WSU, we began to focus primarily on the original specific aims described in the 
RO1 research grant written by Carol Brenner and Barry Bavister, R01-HD045966-01: Defects in 
Mitochondria Impacting Primate Oocyte Quality.  The specific aims of this grant were: to 
determine the frequency and percentage of mtDNA deletions in primate oocytes and early 
embryos, and to determine the localization of active mitochondria in primate oocytes and early 
embryos, measure the activity of these mitochondria, and correlate these measurements with 
oocyte competence.  Previous studies involving aging effects of mitochondria on oocytes were 
also included in the direction taken with experiments at that time.  Therefore, it became 
important that we proceed in two directions in order to encompass previous work performed by 
our laboratory; aging and preimplantation development.  In Specific Aim 3, we set out to 
determine; 1) if there were mutations in the mtDNA control region associated with the aging 
phenomenon, 2) if there were mutations in particular regions of interest within the mitochondrial 
polymerase, PolG, associated with aging, and 3) if there were mutations in the mtDNA control 
region associated with failure of oocytes to resume meiosis prior to fertilization.  We found no 
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correlation between aging or failure of meiotic resumption prior to fertilization with mutations in 
either the mitochondrial control region or the only known mitochondrial polymerase, PolG 
(Chapter 4).  While it is clear that mtDNA damage and repair mechanisms most certainly have 
an impact on mitochondrial replication and transcription in skeletal muscle and other post-
mitotic tissues, other factors must be contributing to oocyte and embryo quality and 
preimplantation development.   
Therefore, in order to improve the quality of oocyte and embryonic material used for 
further analyses, we began onsite collaborations with the Caribbean Primate Research Center.  
Through improvements made to the existing gonadotrophin stimulation regimens used at the 
CPRC, involving the reduction of total rFSH used per stimulation cycle, the addition of rLH to 
all cycles and the use of biological hCG in lieu of recombinant hCG, we were able to 
dramatically improve the number of MII oocytes collected as well as significantly reduced the 
number of unusable GV oocytes collected, as well as reducing the hormone cost of every cycle 
by reducing the dose of FSH by half, without any reduction in the number or quality of oocytes 
collected (Chapter 5). 
With improvements made to the rhesus macaque IVF cycles, and the collection of 
reliable, quality material, we have been able to correlate, for the first time, expression of genes 
involved in mitochondrial dynamics and movement, as well as mtDNA replication, with specific 
time points in preimplantation development that have been previously shown to be important in 
mitochondrial activity.  Unfortunately, due to the limitations of equipment available at the 
CPRC, we were not able to correlate mitochondrial movement and localization with expression 
analysis of genes involved in mitochondrial dynamics and movement.  However, we do believe 
these processes to be linked and future studies employing confocal microscopy have been 
proposed for correlation.  We have shown that while critically involved in chromosomal 
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normality and stability (Dupont et al., 2009), oocyte maturation from the time of collection (33-
34 hrs post hCG) to the time of insemination (37-38 hrs post hCG) does not influence the 
mitochondrial contribution to the processes of fertilization and syngamy.  Furthermore, we have 
shown the processes of mitochondrial fusion, fission, movement and transcription are all strongly 
associated with each other throughout critical time points of preimplantation development 
(Chapter 6).   
We determined that embryos inseminated under high O2, and then split into either low or 
high in vitro O2 conditions after fertilization exhibited no differences in levels of gene expression 
(Chapter 6).  In conjunction with the high levels of gene expression seen in zygotes at the time of 
syngamy, these data indicate that oxygen concentration conditions may influence embryo culture 
at an earlier time point than day 3, namely during fertilization and syngamy when there is a 
higher metabolic demand for ATP.  We propose other time points of high metabolic demand 
(blastocyst stage) may also be influenced by oxygen concentration during in vitro culture.  
Similar studies where oocytes are fertilized under either low or high O2 concentration have been 
proposed in order to determine at what point oxygen tension becomes critical.   
Furthermore, not only have we been able to show, for the first time, that expression of 
genes involved in the control of mitochondrial fusion, fission, movement and replication 
fluctuates depending upon the stage of development; but that a subpopulation of high quality 
oocytes, zygotes and embryos may be identified based upon level of mitochondrial fusion, 
fission movement and replication gene expression (Chapter 6)   
Due to the ethical limitation of using human oocytes and embryos for invasive studies, 
we have shown here that the rhesus macaque is an excellent model used in lieu of human 
material.  Destructive analyses used in these studies will likely never be allowed to be employed 
on human material.  Without the use of clinically translational models, such as the rhesus 
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macaque, the methods used to determine why fertility and reproductive problems exist as well as 
methods to identify, prevent and treat issues and diseases related to fertility and mitochondria, 
would be profoundly inadequate.  
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ABSTRACT 
THE IMPACT OF MITOCHONDRIA ON PREIMPLANTATION DEVELOPMENT IN 
THE RHESUS MACAQUE 
by 
TIFFINI C. GIBSON 
AUGUST 2010 
Advisor: Carol Brenner, Ph.D. 
Major:  Physiology 
Degree: Doctor of Philosophy 
Assisted Reproduction Technologies (ART) have been used to treat infertility since 1790.  
In the centuries following, dramatic advances have been made in the field of infertility research 
through the employment of a variety of species.  Despite these advances, determination of oocyte 
and embryo quality remains largely subjective.  Ascertainment of methods to measure oocyte 
and embryo quality to improve selection in ART clinics and increase pregnancy success rates is 
imperative.  These methods are only possible with a more comprehensive understanding of the 
cellular and molecular properties of oocytes and preimplantation embryos.  A key component of 
all cells, including oocytes and embryos, is the mitochondrion, which produces energy and 
maintains its own DNA for encoding proteins necessary for energy production.  Defects in either 
the proteins responsible for energy production, the mitochondrial DNA (mtDNA) genome, or 
other contributing factors can lead to loss of oocyte competence and embryo quality.  Human 
oocytes and embryos would be the optimal material to use for performing studies on 
preimplantation development.  However, practical and ethical constraints prevent the use of 
human material for intensive, potentially terminal studies; thus, compelling researchers to find 
and use suitable animal models instead. The non-human primate (NHP) is the most befitting 
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animal model for human reproduction due to evolutionary closeness and the dramatic similarities 
in reproductive function and preimplantation development.  Furthermore, because studies in 
human preimplantation development are restricted to the use of discarded oocytes from infertility 
clinics, the use of the NHP has established the rhesus macaque as an excellent research model for 
human reproduction due to the availability of normal, viable oocytes and embryos from fertile 
animals.  Therefore, the overall goals of this study were to evaluate mitochondria in NHP 
oocytes and embryos and to determine how mtDNA mutations and mitochondrial function affect 
oocyte and embryo quality.   
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